A Cantilever Papillary Muscle Repositioning Device for the Elimination of Mitral Regurgitation by Healy, Danielle Kathleen et al.
Worcester Polytechnic Institute
Digital WPI
Major Qualifying Projects (All Years) Major Qualifying Projects
April 2016
A Cantilever Papillary Muscle Repositioning
Device for the Elimination of Mitral Regurgitation
Danielle Kathleen Healy
Worcester Polytechnic Institute
Keith Paul Guay
Worcester Polytechnic Institute
Nadjia Hope Edwards
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/mqp-all
This Unrestricted is brought to you for free and open access by the Major Qualifying Projects at Digital WPI. It has been accepted for inclusion in
Major Qualifying Projects (All Years) by an authorized administrator of Digital WPI. For more information, please contact digitalwpi@wpi.edu.
Repository Citation
Healy, D. K., Guay, K. P., & Edwards, N. H. (2016). A Cantilever Papillary Muscle Repositioning Device for the Elimination of Mitral
Regurgitation. Retrieved from https://digitalcommons.wpi.edu/mqp-all/1397
Project Number: GRG-1601 
 
A Papillary Muscle Repositioning Device  
for the Elimination of Mitral Regurgitation 
 
 
 
A Major Qualifying Project Report submitted to the faculty of 
 
WORCESTER POLYTECHNIC INSTITUTE 
 
In Partial Fulfillment of the Requirements for the degree of Bachelor of Science 
 
 
Date Submitted: 
April 27, 2016 
 
Submitted by: 
 
 
 
Nadjia Edwards: __________________________ 
 
 
Keith Guay: ______________________________ 
 
 
Danielle Healy:___________________________ 
 
 
 
 
 
 
 
Approved: 
 
Professor Glenn Gaudette, Ph.D:____________________________ 
 
 
Professor John Sullivan, Ph.D:______________________________ 
 
Table of Contents 
 
Table of Contents ...........................................................................................................................................2 
Acknowledgements ........................................................................................................................................5 
Abstract ..........................................................................................................................................................6 
List of Figures .............................................................................................. Error! Bookmark not defined. 
List of Tables .................................................................................................................................................8 
I. Introduction ............................................................................................................................................9 
II. Literature Review .............................................................................................................................11 
Physiology of Mitral Valve and Papillary Muscles .................................................................................11 
Papillary Muscle Rupture ........................................................................................................................15 
Papillary Muscle Repair ...........................................................................................................................15 
Mitral Valve Repair .................................................................................................................................16 
Fibrin Mircothreads and Regeneration ....................................................................................................16 
Stem Cells as a Means of Regeneration ...................................................................................................17 
Cell Integration in Scaffolds ....................................................................................................................18 
Cell Integration in Hydrogels ...................................................................................................................19 
Ischemic Left Ventricular Distortion .......................................................................................................21 
Polymer Integration .................................................................................................................................23 
Nitinol ......................................................................................................................................................27 
III. Project Strategy ................................................................................................................................27 
Initial Client Statement ............................................................................................................................27 
Revised Client Statement .........................................................................................................................28 
Functions and Objectives .........................................................................................................................28 
Project Approach .....................................................................................................................................31 
IV. Design Process .................................................................................................................................31 
Needs Analysis .........................................................................................................................................31 
Length of Papillary Muscle: .................................................................................................................32 
Displacement of Papillary Muscle after Myocardial Infarction: .........................................................33 
Geometric Orientation during Systolic and Diastolic Cardiac Cycles: ...............................................33 
Strain on Papillary Muscles during Cardiac Cycle: .............................................................................33 
Maximum Forces on Papillary Muscle: ...............................................................................................34 
Angular Displacement of Papillary Muscle after Myocardial Infarction: ...........................................34 
Pressures of Diastole and Systole: .......................................................................................................34 
Pressure of Diastolic and Systolic after Myocardial Infarction: ..........................................................35 
Design Requirements and Functions .......................................................................................................35 
Functions ..................................................................................................................................................36 
Specifications ...........................................................................................................................................36 
Important Industry Standards ...................................................................................................................37 
Conceptual Designs .................................................................................................................................37 
Design 1: Webbed Polymer Coating ........................................................................................................38 
Design 2: Surface Modification for Chordae Attachment .......................................................................39 
Design 3: “Silly Putty” Attachment .........................................................................................................39 
Design 4: Attachment of Cardiac Cells to Surface ..................................................................................40 
Design 5: “Suction Cup” Method ............................................................................................................41 
Design 6: Full Replacement with Polymer ..............................................................................................42 
Design 7: Insertion of Polymer Loop .......................................................................................................43 
Design 8: Papillary Anchor ......................................................................................................................43 
Design 9: Velcro Design ..........................................................................................................................44 
Design 10: Conducting Polymer Addition ...............................................................................................45 
Design 11: Grow a New Papillary Muscle ..............................................................................................45 
Design 12: Collagen Cross-linked Hydrogel with Cardiac Cells ............................................................46 
Design 13: Annuloplasty Ring Idea .........................................................................................................47 
Design 14: Retractable Suture Method ....................................................................................................47 
Design 15: Nitinol Cantilever Design ......................................................................................................48 
Design 16: PTFE String through Heart ....................................................................................................49 
Alternative Designs ..................................................................................................................................50 
Design 1: Webbed Polymer Coating ....................................................................................................51 
Design 2: Surface Modification for Chordae Attachment ...................................................................51 
Design 3: “Silly Putty” Attachment .....................................................................................................51 
Design 4: Attachment of Cardiac Cells to Surface ..............................................................................52 
Design 5: “Suction Cup” Method ........................................................................................................52 
Design 6: Full Replacement with Polymer ..........................................................................................52 
Design 7: Insertion of Polymer Loop ...................................................................................................53 
Design 8: Papillary Anchor ..................................................................................................................53 
Design 9: Velcro Design ......................................................................................................................53 
Design 10: Conducting Polymer Addition ...........................................................................................54 
Design 11: Grow a New Papillary Muscle ..........................................................................................54 
Design 12: Collagen Cross-linked Hydrogel with Cardiac Cells ........................................................54 
PTFE String through the Papillary Muscle ..........................................................................................55 
Nitinol Cantilever .................................................................................................................................56 
Final Design .............................................................................................................................................57 
Feasibility Study ......................................................................................................................................59 
Design Calculations .................................................................................................................................61 
Modeling ..................................................................................................................................................62 
Preliminary Data ......................................................................................................................................62 
V. Design Verification ..............................................................................................................................64 
AutoDesk ForceEffect and Calculations ..................................................................................................64 
SolidWorks Nitinol Material Model Simulation ......................................................................................67 
VI. Final Design Validation ...................................................................................................................70 
VII. Discussion ........................................................................................................................................72 
ABET Criteria ..........................................................................................................................................74 
Economics ............................................................................................................................................74 
Environmental Impact ..........................................................................................................................74 
Societal Influence .................................................................................................................................75 
Political Ramifications .........................................................................................................................76 
Ethical Concern ....................................................................................................................................76 
Health and Safety Issue ........................................................................................................................77 
Manufacturability .................................................................................................................................78 
Sustainability........................................................................................................................................79 
VIII. Conclusion and Recommendations ..................................................................................................79 
References ....................................................................................................................................................82 
Appendix A: Hand Calculations for Cantilever Beam ................................................................................87 
Appendix B: Lab Notebook Scans ...............................................................................................................89 
 
 
 
 
 
 
 
 
 
 
 
 Acknowledgements 
 
We would like to thank the following members and faculty of Worcester Polytechnic Institute for 
their assistance in our Major Qualifying Project. Our advisors Professor Glenn Gaudette and John 
Sullivan. Lisa Wall for all of her assistance during our lab testing. As well as Josh Gershlak and 
Emily Abbate for their feedback and advice.  
Furthermore, we would like to thank Professor Makarov, Omar Younis, and Khashayar Rafatzand 
for their contributions to our project.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
 
Post myocardial infarction can induce mitral regurgitation, which can lead to pulmonary 
hypertension, atrial fibrillation, and heart failure. Current devices that mitigate this problem put 
patients on anticoagulants for life or require replacement surgeries approximately every ten years. 
Our team created a minimally invasive medical device that we believe, based upon our analyses and 
preliminary results, requires a one-time surgical procedure and cuts down on recovery time. This 
device is inserted into the papillary muscle where it maneuvers the muscle into a new orientation 
allowing for proper closure of the leaflets, eliminating mitral regurgitation. Device specifications 
were determined through experiments and simulations run through SolidWorks and Autodesk 
ForceEffect. The results of our project suggest that our device could work in vivo and return proper 
functioning of the heart, but further testing is required. 
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I. Introduction 
 
The heart is composed of four valves that control direction of blood flow. The flow is 
unidirectional through the various chambers of the heart. Oxygenated blood flow from the lungs 
to the “left” heart, or left ventricle, is controlled by the aortic and mitral valves. Blood flow to the 
“right” heart, or right atrium, is formed by the pulmonic and tricuspid valves. Between the left 
ventricular chamber and the aorta is the aortic valve. This aortic valve stops blood from traveling 
back into the left ventricle after circulation. Between the left atrium and left ventricle is the mitral 
valve. The mitral valve stops blood from leaking into the left atrium during systole (Mount Sinai, 
2005).  
The function of the papillary muscle is to prevent prolapse or “ballooning” while the heart is 
in systole. It allows blood to flow from the atrium into the left ventricle without having reversal of 
blood flow back into the atrium, causing regurgitation (Mount Sinai, 2005). The papillary muscles 
contract before the ventricular musculature from impulses received from the moderator band. 
Because of this, there is a tension applied to the chordae tendineae, which closes the AV valves 
and limits movement of the bicuspid. The result of this is the prevention of backflow (Hetzer, 
2011).  
Myocardial infarction (MI), commonly known as heart attacks, is defined as “the irreversible 
necrosis of heart muscles, only secondary to prolonged ischemia” (Jolly, 2003). According to 
statistics, half a million Americans suffer from myocardial infarction annually, 1% of which 
experience papillary muscle rupture post MI and 5% of which contribute to mortality after acute 
MI (Jolly, 2003). 
Papillary Muscle Rupture (PMR) most commonly occurs 2-7 days after the initial infarct; it is 
believed that the PMR occurs post MI because the preserved contractility exerts increased stress 
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on the already compromised papillary muscle, ultimately leading to rupture (Grasso, 2014). 
Papillary muscles maintain valvular competence within the mitral valve. Without proper function 
of these two muscles, the leaflets cannot close properly, which allows for blood to leak back into 
the mitral valve each time the left ventricle contracts, and ultimately experience mitral 
regurgitation (Fradley, 2011). Out of the two papillary muscles within the ventricular wall, the 
posteromedial papillary muscle is six to twelve times more likely to rupture because it’s only 
source of blood supply is through the posterior descending artery (Jolly, 2003). However, rupture 
of the anterolateral papillary muscle or both is possible. Complete rupture of both papillary 
muscles usually results in immediate pulmonary edema, cardiogenic shock, and death. Diagnosis 
of PMR is found through the use of an echocardiography or right heart catheterization. The 
holosystolic murmur is essential to listen for when checking for papillary muscle rupture (UCSF, 
2004). For a rupture in the posteromedial papillary muscle, the murmur radiates to the left sternal 
border and may be confused with the murmur of the VSD or aortic stenosis. Anterolateral papillary 
muscle rupture usually demonstrates a new pansystolic murmur that is audible at the cardiac apex 
and radiates to the axilla or the base of the heart (Grasso, 2014).   
Researchers and businesses are working hard to find solutions to the current problems that 
arise from myocardial infarction. The current patents and solutions are specific to certain aspects 
of the papillary muscle and do not encompass a large array of different problems associated with 
myocardial infarction. Analyzing all current methods of success will help our team to create a 
solution to the initial client statement.  
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Project Goal   
The project goal is to fix mitral regurgitation when there is papillary muscle displacement in 
the left ventricle due to myocardial infarction. Our group plans to fix the new orientation of the 
leaflets due to this change, through the repositioning of the papillary muscle. This will be 
accomplished through the use of a nitinol cantilever that will be inserted through the outside of the 
heart. Port access surgery will be the choice of insertion for this device. The repositioning of the 
papillary muscle will cause the leaflets to close properly in order to eliminate mitral regurgitation.   
II. Literature Review 
 
Physiology of Mitral Valve and Papillary Muscles 
 
The heart contains four valves that control the direction of blood flow. Blood flow is 
unidirectional through the various chambers of the heart. The left ventricle is composed of the 
aortic and mitral valves. These valves control the flow of oxygen-rich blood from the lungs to 
the body. The right valve is composed of the pulmonic and tricuspid valves. These valves control 
the flow of oxygen-depleted blood from the body to the lungs. Between the left ventricular 
chamber and the aorta is the aortic valve. This aortic valve stops blood from traveling back into 
the left ventricle after circulation. Between the left atrium and left ventricle is the mitral valve. 
The mitral valve stops blood from leaking into the left atrium during systole (Mount Sinai, 
2005).  
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There are two left ventricular papillary 
muscles, the anterolateral and posteromedial 
papillary muscles, which extend from the left 
ventricular free wall and attach to the two mitral 
leaflets (also known as cusps) seen in figure 1. These 
small myocardial structures have a general thickness 
similar to that of the left ventricular wall or 
ventricular septum. The specific location of the 
papillary muscle various between each person but commonly located “mid one-third of the left 
ventricular chamber”. The two muscles are held firmly to the walls and each other by trabeculae. 
The anterolateral papillary muscle is slightly longer and narrower than the posteromedial papillary 
muscle and has a dual blood supply, coming from both the left anterior descending coronary artery 
and circumflex coronary artery. The posteromedial papillary muscle only has one blood supply, 
the posterior descending artery. Its sole dependent on the posterior descending artery makes the 
posteromedial papillary muscle six to twelve times more likely to rupture than the anterolateral 
papillary muscle (Jolly, 2003).  
The primary responsibility of the papillary muscles is to prevent prolapse, or “ballooning”, 
while the heart is in the systole phase. This means that it will only allow for blood flow to go from 
the atrium into the left ventricle without reversing back into the ventricle and causing regurgitation 
(Mount Sinai, 2005). The papillary muscles receive a direct impulse from the moderator band, 
causing it to contract before the rest of the ventricular musculature. This allows for tension to be 
applied to the chordae tendineae, thus closing the AV valves and limiting movement of the 
Figure 1:  Diagram of the Left Ventricle 
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bicuspids by placing them in an almost vertical direction, allowing for effective and unstressed 
closure and ultimately preventing backflow (Hetzer, 2011).  
Projecting from each papillary muscle in a fan-shape pattern are several chordae tendineae 
(Roberts, 1972). These tendineae are composed of 80 % collagen and 20 % elastic fibers, all 
encased by an elastin mesh about forty micrometers longs and that itself is surrounded by a single 
layer of endothelial cells (Millington-Sanders, 1998). The wavy arrangement of collagen and 
surrounding elastic fibers is well suited to handle the cyclical stresses in which the chordae are 
continuously subjected to. They also act to store and dissipate energy (Dennis, 1986). They are 
primarily responsible for the end-systolic position of both the anterior and posterior leaflets. 
During ventricular systole, the low pressure in the atrium causes the AV valves to evert into the 
atrium; the chordae tendineae, with the help of the papillary muscles, will act as a tethering 
component and prevent the valves ability the flap back into the atrium and cause regurgitation.  In 
order to function properly, the chordae tendineae must have a high degree of elasticity as well as 
considerable strength and endurance (Dennis, 1986). The chordae have the ability to bear the 
weight of the entire heart (Anatomy Expert, 2015).  Any type of rupture to one or more tendineae 
will result in retrograde flow and cause cardiac dysfunction (Anatomy Associates, 2015).  On 
average a papillary muscle will have about twelve chordae tendineae per head, all about 15-20 mm 
in length and 0.45 mm in diameter (Dennis, 1986).  As they rise to meet the mitral valve, they 
subdivide into different layers: the primary, secondary, and tertiary.  
The primary, or marginal, chordae attach to the free margins of the mitral leaflets. Thinner 
primary chords roles are to maintain leaflet apposition and facilitate valve closure. Failure to do 
so will result in mitral regurgitation. Secondary, or basal, chordae have the role of maintaining 
normal left ventricle size and geometry. Improper functioning of these chordae will result in mitral 
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regurgitation. The thick and long chords of secondary chordae are called strut, stay, or principal 
chords. They are located at the 4 and 8 o’clock positions on the undersurface of the anterior mitral 
leaflet. These structures make up the anatomic interface between the musculature of the left 
ventricle myocardium (at the papillary muscles) and the mitral annulus (at the fibrous trigones), 
by emerging from the papillary muscles to the dense collagen network of the anterior mitral leaflet, 
thus allowing for papillary-annular or ventricular-valvular continuity. Loss of tension is 
transmitted from the PMs to the ventricle epicardial fibers, with which they form a continuous 
syncytium. Resultant changes in fiber orientation are associated with a measurable decrease in 
longitudinal strain (Medscaoe, 2015).  
The mitral valve is composed of two leaflets. One has a long anterior with a narrow base 
and the other has a shorter posterior with wider attachments. Within the posterior leaflet there is 
the lateral, middle, and medial scallop. With the middle being the largest of the three. Carpenter 
Classification or Duran Classification can be used to classify the leaflet. In Carpenter 
Classification the scallops of the leaflets are defined as P1 (anterolateral), P2 (middle), and P3 
(posteromedial). And the corresponding anterior parts are classified as A1-A3. The next 
classification method is Duran Classification. This method defines the leaflets by a chordal 
insertion that is based on the two groups of papillary muscles. The anterior leaflets are divided by 
the corresponding chordae tendineae crossings from the anterolateral papillary muscle. The same 
is for the A2 portion of the leaflet that corresponds to the chordae tendineae from the posteromedial 
papillary muscle. For the posterior leaflet scallops, they are divided into P1 (anterolateral), P2 
(posteromedial) and then the middle scallop is divided into PM1 and PM2 by the chordal origins 
(Shah, 2010). 
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Papillary Muscle Rupture 
 
Papillary Muscle Rupture (PMR) is a detrimental effect of post-acute to moderate 
myocardial infarction (MI). In a meta-analysis by Kinn et al, it was found that PMR is the cause 
for 1-5% of mortality in acute MI. In most cases, PMR occurs in patients with cardiogenic shock 
post-MI; the earlier stated meta-analysis found about 55% of mortality was due to mitral 
regurgitation. During myocardial infarction, the left ventricle maintains adequate systolic 
functioning, allowing shear forces to be exerted on the papillary muscles (Hetzer, 2011). When the 
muscles undergo rupture, they no longer have the ability to apply tension to the chordae, resulting 
in an insufficient closing of the mitral leaflets, and ultimately mitral regurgitation.   
Papillary Muscle Repair 
 
The two papillary muscles are attached to leaflets of the mitral valve by the chordae 
tendineae. Because of the attachment of the papillary muscles to the leaflets, if there is rupture, the 
leaflet can be affected as well (Selder, 2015). Papillary muscle rupture can be repaired in a few 
different ways. One of the most common is to replace the mitral valve with a prosthetic valve. 
Another method is mitral valve repair. In this method, the ruptured papillary muscle head is 
reattached to either the bottom of the papillary muscle or the left ventricle. This can be done with 
or without using ring annuloplasty (Medscaoe, 2015). Mitral valve prolapse occurs when there is 
displacement of the superior leaflet tissue into the left atrium and it goes past the mitral annular 
plane. This could be either flail of the mitral valve or billowing valve with free-edge prolapse. The 
flail occurs when there is rupture of the chordae. The chordae tendineae snap causing the leaflets 
to be flail. This flailing causes the leaflets to no longer provide the strength to prevent blood from 
flowing backwards into the left atrium. The chordae tendineae are prone to rupture, so when this 
occurs to a large amount of them, the leaflets flail (Ahmed, 2013). Less commonly, when there is 
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papillary rupture, there will be flail valve prolapse when the mitral valve undergoes myocardial 
infarction. The billowing valve occurs when there is excess tissue in the leaflet or if there is chordal 
elongation. 
Mitral Valve Repair  
 
There are current surgical procedures that can help repair the mitral valve. Common 
surgical procedures are leaflet resection. Carpenter developed the technique called quadrangular 
resection to help treat posterior leaflet prolapse. In this method the prolapsed area is removed from 
the leaflet and it is repaired by plication of the annulus. After the quadrangular resection has 
finished an annuloplasty ring is inserted. However, there are issues with this technique, one being 
due to the addition of an annuloplasty ring, there is accelerated flow and turbulence across the 
posterior leaflet because stiffness was increased in this region. The geometry and dimensions of 
the leaflet were altered, as well, by cutting out a certain part. Another procedure that has been used 
is using polytetrafluoroethylene (PTFE) as neochordae. This will add support to the free edge of 
the prolapsing area of the leaflet. PTFE loops are placed on the papillary muscle at its fibrous tip. 
And from there single loops are attached to the posterior leaflet at the prolapsing area. The 
procedure is finished with the insertion of an annuloplasty ring (Holubec, 2013). Other techniques 
used for repair are artificial chords, plication, and leaflet reduction. 
Fibrin Mircothreads and Regeneration 
 
Fibrin microthreads were developed to act as a scaffold that would organize and align 
tissues as well as support fibroblast attachment, proliferation, and alignment. The advantage fibrin 
microthreads has over current scaffolds is the incorporation of fibrin (Murphy, 2008). Fibrin is a 
substance developed by the body during wound healing, making it much more acceptable to the 
body than other scaffolding materials. It is much more elastic than current materials and has unique 
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mechanical strength (Collette, 2015). Fibrin microthreads uses the unique properties of fibrin as a 
provisional matrix to allow for cells to attach and migrate during wound healing. This matrix 
decreases the potential for cells to be washed out of their site of implantation. For the case of 
healing the myocardium after infarction, fibrin microthreads have been inserted in the form of gels 
for cell delivery. Surgeons are going to be much more inclined to incorporate fibrin microthreads 
during surgeries because by attaching microthreads to their needles, they now have the ability to 
deliver stem cells to any location they want within the heart wall (Murphy, 2008). 
Stem Cells as a Means of Regeneration 
 
Embryonic stem cells have self-renewing properties that can be very useful for tissue 
engineering. They can be used for many different tissues including nerves and blood. They are 
very versatile and can be applied directly to the heart. A group from the Harvard Stem Cell Institute 
cultured embryonic stem cells that had the ability to contract on their own. These embryonic stem 
cells could be tested by being incorporating into a decellularized rat heart, to test if heart 
contraction can be produced (Melton, 2011). The way that this is relevant is that if the team could 
take the embryonic stem cells that beat, and seed it in the heart, this could lead to function returning 
to the heart. 
The heart is made up of cardiac muscle. This muscle is striated, does not show fatigue, and 
is separated by intercalated discs. The muscle has a covering that is covered with connective tissue, 
which helps package the fibers (Georgia, 2015). Cardiac cells are interlocked with strong fibers 
and bands of actin protein that counter-act with myosin. These cells are to contract in rhythm that 
allow for the blood to be pumped with power and precision. The pacemaker cells can keep this 
rhythm going but they can also receive bodily signals that can increase or decrease that rate (Inner 
Body, 2015). The topic of interest is that cardiac cells were known to not have regenerative 
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properties. There were some studies that were done that showed that at a smaller rate, some tissue 
could grow back, however, if it is dead then it could be used as an anchor site. 
To go more in depth of the regeneration of the cardiomyocytes, a study was done that took 
carbon-14 and combined it with DNA to renew cardiac cells in the adult heart. The rate is very 
minor of <1 percent but it does lead to the idea that if it could be done a little, it could increase, as 
suggested by the researchers. The many experiments over the years on cardiac stem cells on mice 
were inconclusive due to the shorter life spans. The reason why they used the carbon-14 was to 
have a safer way to conduct the tests on humans. The increase in the number of the cardiomyocytes 
that was postnatal increased based off of the number of the binucleation. The rate of renewal played 
a role in this as well because the younger cardiomyocytes were more likely to have the replacement 
happen. This rate of turnover does decrease with age.  The end result was some limited 
functionality returning after the injury to the heart which adds some potential to the process 
(Bergmann, 2009). 
Cell Integration in Scaffolds 
 
Scaffolds have been used as physical supports to guide organization, growth, and 
differentiation of cells in tissue engineered constructs. They take on the functions of an 
Extracellular Matrix (ECM) in native tissues. The ideal scaffold will have biological cues such as 
binding sites for cells, physical cues such as surface topography, a porous structure with 
interconnectivity for cell migration and for nutrients and metabolites diffusion, controllable 
degradation mechanisms and rates. Typically scaffolds are composed of natural polymeric 
materials, synthetic polymers, ceramics, biodegradable polymers, or polymers with adsorbed 
proteins or immobilized functional groups. However, collagen based scaffolds have shown to have 
an advantage over these types of materials based on its biocompatibility properties. Collagen can 
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be used in its native form or as a denatured gelatin. It has grown to be a popular material used in 
scaffolds due to its abundance in the body, ubiquity, and biocompatibility. They are two forms 
collagen can take when used as the base material for a scaffold: swollen hydrogels or sparse fibers 
in a lattice-like organization, cross-linked by various methods but preferably dehydrated cross-
linking (Trinity College, 2015).  A recent study cultured embryonic and neonatal rat cardiac cells 
on electro spun tubular collagen scaffolds 15 mm long, 4 mm inner, 5 mm outer diameter. After 
3-5 weeks in an HARV bioreactor, the randomized cardiac cells aligned to form sparse 
synchronously contractile networks, on the inside and outside of the tube (thickness of about 20 
micrometers). The cardiac cells displayed registered sarcomeres and randomly distributed gap 
junctions while the tubular collagen scaffold, based on the results of the stress-strain hysteresis, 
and exhibited viscoelastic properties which mimicked that of the papillary muscle (Millard, 2011). 
Cell Integration in Hydrogels 
After myocardial infarction there are a lot of negative occurrences, one being loss of cardio 
myocytes. Human embryonic stem cells have the ability to differentiate into many different cell 
types, including cardiomyocytes and vascular cells. There has been an exploration of using 
biomaterials from decellularized native tissues as cellular or acellular patches and injectable 
hydrogels. Hydrogels are promising because they resemble the extracellular matrix. They are able 
to be designed to hold cells and improve the survival of cells and the differentiation and integration 
into host tissue. In forming hydrogels, aspects of the extracellular matrix have been used in the 
composition. These have included collagen, gelatin, and even extracts from the extracellular 
matrix. However, a downfall to using ECM hydrogels is that there is not a definitive 
characterization of how to form these gels. The Extracellular matrix itself is a very complex 
structure composed of an independent network of fibrous proteins, proteoglycans, and surrounding 
20	
	
molecules. So producing a hydrogel to include all this aspects will require more studies (Duan, 
2011). 
According to the studies performed by Duan et al cardiac ECM hydrogels loaded with 
cardiac progenitors, not containing growth factors, were able to differentiate and mature at a higher 
rate than collagen hydrogels that were produced with cardiac growth factors. It was also discovered 
that using a native cardiac tissue matrix mixed with collagen to create a hydrogel helps provide 
the correct biochemical cues that is important for cardiac regeneration. Collagen type I was used 
to create this hydrogel due to its protein growth promotion, survival rate of cardiomyocytes, and 
because there are copious amounts of it in the adult heart. In order to have human embryonic stem 
cell differentiation into cardiomyoctes, the hydrogel needs to be composed with a high percentage 
of ECM, around 75%. To test how the embryonic cells reacted to various hydrogels, embryoid 
bodies were cultured so that their morphilogial changes and distribution of cardiac cell lineages 
could be calculated. In the hydrogels with ECM around 75%, the embryoid bodies formed a group 
that allowed them to interact and beat synchronously (Dyan, 2011). 
The cells in the 75% ECM hydrogels were able to differentiate and mature, however when 
growth factors were added to the material, this did not occur. In the studies by Duan et al, they 
hypothesized that this was due to the bioactive molecules and growth factors that are present in 
the native cardiac ECM. These factors send the signals for embryoid body differentiation. So, if 
extra growth factors are added this process is altered. Another hypothesis is the long term affects 
from the attachment of excess cytokines to the native ECM. This can inhibit cardiac myogenesis, 
forming of cardiac muscle (Duan, 2011). 
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Ischemic Left Ventricular Distortion 
Ischemic mitral regurgitation is a potential complication of myocardial infarction. It has 
been shown that ischemic mitral regurgitation can result from left ventricular distortion. 
Ventricular distortion results in a dyskinetic or akinetic segment of the wall. The dyskinetic region 
is where the heart contracts at a different time than the rest of the heart and the akinetic region is 
when the heart does not contract (Trinity College, 2015). This distortion displaces the papillary 
muscles which causes the mitral leaflets to tether, restricting their closure. There is a lack of 
therapeutic solutions for left ventricular distortion. The main solution is to perform mitral ring 
annuloplasty, which reduces mitral annular size so that it is less than the normal systolic dimension, 
but does not fix ischemic left ventricular tethering of the leaflets (Hung, 2002).  
The current solutions to ischemic left ventricular distortion are leaflet tethering, relocating 
the papillary muscle, surgical plication of the infarcted left ventricle, leaflet augmentation, and 
placing a patch or discs over the infarct. Another solution is to inject biomaterials into the 
myocardium. This will be used as a tissue bulking agent, aiding in the repositioning of the papillary 
muscle. In research performed by Solis et al PVA was the biomaterial used as the bulking agent. 
This polymer was used because it is biocompatible, bioinert, and can be produced so that it is 
injectable at 90C but also can form a gel at body temperature. Within 5 minutes an encapsulated 
gel was formed. Once this PVA hydrogel is injected into the infarcted myocardium there could be 
possible repositioning of the papillary muscles. This repositioning occurs by tissue displacement 
and changing of the myocardium so that it bulges less. Because a small amount of PVA was 
injected, there was not a change in the function or volumes of the left ventricle. There also was no 
damage to the surrounding myocardial fibers (Solis, 2010). 
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In current studies there is beginning to be an attempt to solve posterolateral papillary 
muscle and ventricular wall displacement with the use of hitching sutures. However, this would 
be added to the current procedure of using an annuloplasty ring. Ischemic mitral regurgitation can 
be improved if the posteromedial papillary muscle is repositioned. The PA hitch, posteromedial 
papillary muscle to posteromedial commissure suture, was used in the testing by S.F Marasco et 
al and pulled the posteromedial papillary muscle up towards the annulus, which relieved some of 
the tethering on the leaflet. This allowed the free edge of the posterior leaflet to rise and meet the 
anterior leaflet. An AL hitch was also used, posteromedial papillary muscle to anterolateral 
commissure suture. This pulled the posteromedial papillary muscle into the middle of the left 
ventricular cavity which pulled the free edge of the posterior leaflet closer to the coaptation point 
on the anterior leaflet. This method has more risks because it runs across the mitral valve orifice, 
which could interfere with the movement of the chordae (Marasco, 2008).   
Another test was performed by J. Hung et al were they hypothesized the papillary muscle 
could be repositioned by placing a Dacron patch containing inflatable balloon over the papillary 
muscles. This could reverse left ventricular remodeling and reposition the infarcted papillary 
muscle toward the anterior mitral annulus, in turn reducing leaflet tethering. The procedure was 
performed by sewing the patch-balloon onto the region of infarction on the myocardium using 
interrupted sutures. Between the patch and the myocardium was an elongated oval balloon. The 
degree of balloon inflation and patch placement were determined in situ by echocardiography 
(Hung, 2002).  
The experiment was performed on 10 sheep that mitral regurgitation was induced in. In 3 
sheep there was a reduction of mitral regurgitation when the patch was placed. The other 7 required 
injection of 5 to 15 mL of saline in the balloon. It was shown that in balloon inflation the papillary 
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muscle shifted anteriorly, causing the bend in the anterior leaflet to be reduced. Also with the 
placement of this patch the mitral regurgitation volume decreased 0.8 mL/beat (Hung, 2002).  
J. Hung et al were able to determine that the placement of this balloon-patch was able to 
provide direct and reversible control of papillary muscle repositioning. An advantage to this 
method was that left ventricular systolic function was not compromised and filling pressures were 
not raised. Further research is needed to be completed on the varying locations and chronicity of 
ischemia and papillary muscle geometry (Hung, 2002).  
Polymer Integration 
 
Polytetrafluoroethylene (PTFE), is a synthetic fluorocarbon polymer commonly used in 
cardiovascular applications based on its unique properties. It is created by free radical 
polymerization (Poly Fluro, 2009). Each carbon on the carbon based backbone chain has a fluorine 
atom attached to it, making it both nonpolar and nonreactive. Being the most electronegative 
element on the periodic table, the fluorine atoms do not share their electrons with neighboring 
atoms which results in a low surface free energy and causes the polymer to be “slippery.” The low 
surface free energy and hydrophobicity of the polymer is the reasons why nothing can stick to 
PTFE (Clough, 2015). Commercially, PTFE may be known as Teflon (Jaganathan, 2014). PTFE 
has a high density (2.15-2.2 g/cm3), high molecular weight (6*106-10*106), low tensile strength 
(17-28 MPa), low modulus of elasticity, low surface tension (18.5 ergs/cm3), and a coefficient of 
friction of 0.1 (Bhat, 2002). Due to its high melt viscosity, PTFE cannot be injected, molded or 
melt extruded, so it is typically used in is powdered form where it is sintered at a temperature 
above 327 degrees Celsius under an applied pressure. This nondegradable polymer has excellent 
chemical and thermal stability, as well as 100% inertness, which allows for complete 
biocompatibility, PTFE can be implanted in the body and excellent tissue-material interaction 
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(Poly Fluro, 2009). Its biocompatibility ratings and temperature stability is much higher than other 
clinically approved polymers such as PVDF, Epoxy, Polypropylene, Nylon, and Polycarbonate. 
Typical biomedical applications of PTFE include sutures, pastes, tubes, strands, sheets, vascular 
grafts, etc. (Poly Fluro, 2009).  
Although PTFE has tremendous advantageous for cardiovascular applications, it does have 
its drawbacks. In most cases, PTFE is considered to have a low wear resistance, but when placed 
under constant pressure, can undergo rubbing or abrasion resulting in wear particles that can cause 
chronic inflammatory problems (Poly Fluro, 2009). 
In 1958, Bill Gore discovered expanded polytetrafluoroethylene (ePTFE), which is now 
commercially known as Goretex (Poly Fluro, 2009). This form of PTFE is typically used in 
external medical devices. The process of creating ePTFE involves heating up unsintered PTFE to 
a temperature between 350-370 degrees Celsius while it is restrained in a device capable of 
stretching it at high rates. The polymer may be stretched for a time period ranging from a few 
seconds to an hour. The higher the stretch rate and temperature, the more uniform of a matrix will 
be produced. This process is called “amorphous locking”. Once the polymer has reached its desired 
expansion, it is cooled and removed (Poly Fluro, 2009). ePTFE has a higher permeability to gases 
and liquid then PTFE due to its porous structure, has a crystallinity of 95% (significantly higher 
than any competing commercial product with unexpanded parts), as well as a higher flex life, 
improved tensile strength, and maximum service temperature than typical PTFE. Its airflow rate 
is 2-15,000 mL/cm2, methanol flow rate 1-10,000 cm2, water entry pressure of 0-250 psi and a 
pore size ranging from 0.02-40 micrometers (Poly Fluro, 2009). There are no confirmed reports of 
allergic reactions to Gore ePTFE to date and studies have tested the product to be non-
carcinogenic, non mutagenic, non pyrogenic, and not systemically toxic (Poly Fluro, 2009). 
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However, thrombus formation have been reported on the surface on ePTFE grafts that have been 
implanted in vivo (Poly Fluro, 2009).  
The use of PTFE sutures to repair mitral regurgitation has shown high success rates in 
clinical studies. One study used PTFE sutures as chordae reconstruction of the mitral valve after 
myocardial infarction. This study was performed on a total of seven patients, three of which 
suffered from prolapse of the anterior leaflet, two from posterior leaflet, and two who ended in 
hospitalized death due papillary muscle dysfunction. A total of five out of seven patients ended in 
successful chordal reconstruction through the use of PTFE sutures (Poly Fluro, 2009). 
Another study tried similar techniques to repair mitral valve after myocardial infarction by 
focusing on the reconstruction of the chordae tendineae with ePTFE sutures. There was a total of 
22 patients involved in this study, all having gone through moderate-to-severe MI with prolapse 
of posterior leaflets. Each patient underwent mitral valve repair which involved the reconstruction 
of artificial chordae with ePTFE sutures without leaflet resection. The final results showed two 
failures, both of which having to receive reoperation, nonexistent mitral regurgitation in 6 patients, 
trivial regurgitation in 10 patients and mild regurgitation in 4 patients. The systolic and diastolic 
dimensions of the left ventricle decreased significantly as well (p<0.01). The PTFE sutures 
exhibited similar flexibility to that of natural chordae. Overall, the results of the study supported 
the hypothesis that PTFE sutures preserved favorable relationships among leaflet tissues, chordae, 
and the papillary muscle. The most important factor considered throughout this study was 
accurately determining the proper length of the reconstructed chordae. It is important to maintain 
a predetermined distance between the apex and mitral annulus so the natural geometry of the left 
ventricle is maintained during operation. In most cases, the suture was tied at the leaflet level where 
the opposite leaflet was stretched (Tomita, 2004).  
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In very few studies has PTFE sutures resulted in failure or major drawbacks. Kobayashi and 
associates (Kobayashi, 1996), found that within a year, their artificial PTFE chordae tendineae 
became covered by a host fibrosa which resulted in thickening and stiffening and ultimately mitral 
valve dysfunction. One study reported calcification in an experimentally isolated PTFE chordae, 
but otherwise has not been reported in any other cases (Tomita, 2004).  
As the interest of PTFE chordae tendineae began to grow, a chordae replacement study 
compared its properties against traditional leaflet resection to fix mitral regurgitation. The study 
took 211 patients, all of whom underwent isolated mitral valve repair for degenerative posterior 
mitral leaflet prolapse and all of whom received an annuloplasty ring. Results were collected after 
5 years. 156 patients went under leaflet resection and 55 received PTFE neochordae. Results 
showed a 98.2 % in PTFE and 93.9% in resection group from a mitral repair study, freedom from 
all cause reoperation 100% in PTFE, 93,9% in resection, freedom from mitral regurgitation 89% 
PTFE and 96.1 in resection, freedom from endocarditis 100% PTFE and 98.3% in resection group. 
Overall, PTFE neochordal repair can allow for a larger mitral annuloplasty ring and is associated 
with a better hemodynamic performance then leaflet resection (Ragnarsson, 2015).   
There have been advances in tissue engineering to make surfaces more biocompatible through 
coatings and surface modifications. These coatings have been incorporated into different cardiac 
implants and devices to make devices more suitable for implantation in the heart. Some of these 
methods have included adding a layer of polyethylene glycol (PEG). PEG is an important polymer 
because it can combat the inflammatory effects and has photolithography capabilities that can 
pattern different electrodes to accept stimulation (Ravenscroft-Chang, 2010). 
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Nitinol 
 
Nitinol has been widely used in cardiac applications due to its shape memory characteristics. 
Nitinol can be given desired properties by treating it a certain way. One treatment is heat treating 
and it determines the final properties of the Nitinol wire and can be modified to a desired outcome.  
This is due to the crystal structure of the different alloys. While in the martensitic phase, the Nitinol 
is able to be bent into a shape that can be remembered. This 
aligns the crystals in a different structure that can then be 
heated to a certain temperature to “lock” them in a shape 
that can be remembered later on. The different phases 
between austenitic and martensitic are shown in Figure 2.  
The crystal structures can then align and then be 
remembered and then once the object is deformed, it can be 
returned to that when heat is applied.  
III. Project Strategy  
 
Initial Client Statement 
The following client statement was presented by advisor Professor Glenn Gaudette for this Major 
Qualifying Project.  
“Design a functional replacement for the papillary muscle that incorporates the use of fibrin 
microthreads. Design considerations include implantability, handling and function.” 
Background on the topic of interest was also provided to give more insight into the problem:  
“The papillary muscles are small muscles located in the ventricles of the heart.  These 
muscles are connected to the cusps of the atrioventricular valves via the chordae tendineae, 
Figure 2. Nitinol Austenite to Martensite 
phase change 
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and prevent inversion and prolapse of the valves. Damage to these muscles leads to valve 
prolapses and blood regurgitation increasing the chances of severe complications in the 
heart. Cardiac surgeons generally prefer to keep native atrioventricular valves rather than 
replace them with mechanical or bioprosthetic valves. One method to do this includes re-
orienting the valve leaflets. A tissue engineered papillary muscle may be able to re-align 
the valve leaflets while also providing the contractile benefits of a normal papillary 
muscle.” 
Our initial client statement had the implied solution to use fibrin microthreads as a replacement of 
the papillary muscle. After investigating and going through the design process, our group came to 
the conclusions that although this implied solution was presented to us by the client, that did not 
mean it was the best option in solving it. We found we did not need fibrin microthreads to replace 
the papillary muscle, we just needed to bring the edges of the mitral valve leaflets together again 
to eliminate mitral regurgitation. Once we were able to think outside the confinement of the initial 
client statement, we were able to come up with a revised client statement as well as a list of 
functions and objectives that better suited the problem needed to be solved. 
Revised Client Statement 
 “Design a device that will repair closure of the leaflets in the left ventricle of the heart 
after myocardial infarction, through the repositioning of the papillary muscles. Design 
considerations include being implantable, minimally invasive, and biocompatible” 
Functions and Objectives  
  
A list of functions and objectives was developed based on the initial and revised client statement.  
• Non-immunogenic: The device cannot cause an immune response within the body 
that could lead to additional health problems.  
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• Non-toxic; biocompatible: the device and materials need to be able to welcome 
cell growth so they do not cause problems and kill the cells that will be growing on 
them. If the device causes more problems for the body, given that it will be located 
in the heart, then more harm could occur than benefit. 
• Degradation rate should match the rate of new tissue formation (initial): The 
device and tissues have to be matched with a degradation rate so one does not fail 
sooner than the other. It cannot give off negative byproducts from degrading to 
ensure that its safe for internal body use, especially when it has contact with the 
blood stream. 
• Provide physical support for cardiac cells when seeded (initial): Making sure 
the cells are able to grow properly and they have enough support will help ensure 
that they can grow properly and become proper cardiac cells. This also ensures that 
they should be grown on a surface that will not negatively impact their properties. 
• Provide chemical and biological cues which mimic the papillary muscle 
(initial): If the material used can either take electrical signals to contract properly 
(if needed) or even be able to know when the heart needs to pump more or less to 
follow bodily function. 
• Display viscoelastic material properties (initial): Ideally having a viscoelastic 
material should last longer and display similar properties to the original physiology 
of that its replacing. 
• Light weight (revised): Having a low weight, high strength material would be ideal 
in the heart for minimal interference.  
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• Easily manufactured into desired shape (revised): Shape memory will ensure 
that our material is not overly brittle. 
• Biomimetic strength to the papillary muscle: Having the material used match the 
shape of the papillary muscle will ensure the elimination of extraneous cost and 
less material waist.  
• Contract with the left ventricle 
• Account for cell viability, proliferation, and differentiation during and after 
engraftment: making sure that the cells don’t continuously grow into a mass that 
becomes a problem down the road would be another important factor.  
• Cannot tear the leaflets (revised): making sure that the device does not break the 
leaflet or does not damage the heart will be important. The device has to be securely 
anchored so that does not cause damage to the patient. 
• Alters the orientation of the leaflet to close properly and stop mitral 
regurgitation (revised): the device cannot cause more problems than it is trying to 
fix. If the valves and leaflets get altered too much then this would cause more harm 
than benefit. 
Based on these functions and objectives, a pairwise comparison chart was used to help organize 
the major function on the list (Table 1).  
Table 1: Pairwise Comparison Chart 
Pairwise Comparison Chart 
  Biocompatible 
Cell 
Growth 
Mechanical 
Properties Contractile Total 
Biocompatible x 1 1 1 3 
Cell Growth 0 x 0 1 1 
Mechanical 
Properties 0 1 x 1 2 
Contractile 0 0 0 x 0 
31	
	
 
Through the chart, biocompatibility and strong mechanical properties showed to be the 
most important aspects in the design. It also showed that contractile properties were not as 
important, meaning this may not need to be incorporated into the final design. These tests allowed 
a revised client statement to be produced.  
Project Approach 
For our project approach, we intend to design a papillary muscle repositioning device using 
the shape memory alloy nitinol. We plan on developing a proof of concept to show that our device 
will work when applied to cardiovascular applications. We will use computer aided design 
simulations, data analysis, and in vitro experiments to determine if our device will allow for a new 
orientation of the papillary muscle thus allowing for proper closure of the leaflets and elimination 
mitral regurgitation.  
IV. Design Process  
Needs Analysis 
 
After developing our project approach one the client statement was revised, we specified 
the needs required for our device. The length of the papillary muscle was researched to determine 
the size our device should be. The average displacement of the papillary muscle was calculated to 
help determine the possible vectors needed to return the papillary muscle to its initial position. 
And finally different reactions on the papillary muscle when the heart is in systole and diastole 
were researched to understand how our device should account for those changes.  
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Table 2: Needs Table 
Ranking Need 
6 The material used needs to properly fit the length of the papillary muscle. 
1 It must readjust the papillary muscle to it’s original location and account for 
displacement after myocardial infarction in order to eliminate mitral regurgitation 
which is occurring from improper closure of the leaflets 
3 Account for the maximum forces and pressure changes that act on the papillary 
muscles to assure our material will be able to withstand such force inside left 
ventricle 
5 Account for angular displacement of the papillary muscle after myocardial infarction 
in relation to the myocardial wall 
2 The material we use must be biocompatible so it will be accepted by the body and 
function properly 
8 Calculate how to train the nitinol to desired shape in order to force the papillary 
muscle back to its original location 
4 Solve the problem of mitral regurgitation without causing additional issues 
7 PTFE needs to be the proper length to account for a 10% strain within the cardiac 
cycle 
 
Length of Papillary Muscle: 
 
The material used needs to properly fit the length of the papillary muscle. A study measured 
the length of the papillary muscles of different age groups in Bangladeshi cadaver. Group A where 
<20, Group B were between the ages of 21 to 40 and Group C was 41 to 60 years of age. The mean 
+/- SD length of the anterior papillary muscle in the left ventricle of the heart was 1.53 +/-0.34, 
2.05 +/-0.39 and 2.01 +/-0.25 cm in Group A, B, and C respectively. The mean +/- SD length of 
the posterior papillary muscle in the left ventricle was 1.33 +/- 0.34, 1.95 +/- 0.89, and 1.81 +/- 
0.76 cm (Li, 2014).   
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Displacement of Papillary Muscle after Myocardial Infarction: 
Based off a study, “Ring plus String”, that was conducted to better understand the precise 
3-dimensional geometry changes of the mitral valvular-ventricular complex in chronic ischemic 
mitral regurgitation to better devise a surgical repair technique, the average displacement of the 
posterior papillary muscle after myocardial infarction was 7 +/- 3 mm to the left perpendicular to 
the tip, 8 +/- 5 mm at 45 degree angle of the tip, 1 +/- 1 mm down and for the anterior papillary 
muscle was 3 +/- 2 mm to the left perpendicular to the tip, 1 +/- 1 mm down (Tibayan, 2015). 
Geometric Orientation during Systolic and Diastolic Cardiac Cycles: 
The onset of systolic pressure in the left ventricle causes the length of the papillary muscle 
to increase sharply, reaching its maximum length at the opening of the aortic valve. In the 
geometric orientation of the left ventricle, the mitral annulus is placed somewhat forward, whereas 
the aortic orifice is adjacent and directed upward. The anterior leaflet is oriented parallel with the 
line of flow out of the aorta, meaning that in the systolic cardiac cycle, it is pushed further out of 
the way. The vector of systolic forces is mainly tangential to the anterior leaflet, which, despite its 
large surface area, is protected from stress (Farner, 1973). As long as the mitral valve is open, only 
moderate tangential forces act on the papillary muscle. Pre-tension of the papillary muscles is low 
during diastole. After the valve closes, the pressure in the left ventricle sharply rises to stretch the 
muscle and in turn causes the mitral leaflets to act as a secondary anchoring point for the papillary 
muscle (Duran, 2013). 
Strain on Papillary Muscles during Cardiac Cycle: 
Based off of our research, the average strain on the papillary muscles from systole to 
diastole is approximately 10% (Komeda, 1997 and Semafuko, 1975). 
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Maximum Forces on Papillary Muscle: 
On average, a mean force of 4.1 +/- 9 N is transferred to each papillary muscle from the 
mitral valve and the chordae tendineae. Values found in a study, Forces on the Papillary Muscle, 
measured peak papillary muscle force at 5.3 N in the anterior papillary muscle and 5.1 N in the 
posterior papillary muscle at a left ventricular pressure of 94 mmHg, this is an average range of a 
heart during the systolic phase of the cardiac cycle of a healthy adult (Askov, 2011). 
Angular Displacement of Papillary Muscle after Myocardial Infarction: 
A study called “Angle Displacement during Cardiac Cycle”, obtained short-axis 
measurements of left ventricular cavity at the level of the papillary to obtain individual frames 
were the muscle was in systole and diastole. Degrees of angular displacement of the papillary 
muscle were obtained by subtracting the measured angle in diastole from the measured angle in 
systole. This final value was assumed to represent the degree of angular displacement of the left 
ventricle about its longitudinal axis. The study showed that patients with heart diseases, such as 
myocardial infarction, had a mean papillary muscle angular displacement of 3.2 degrees. Values 
ranged from 0-7 degrees. These results confirmed that patients with mitral regurgitation do not 
have exaggerated left ventricular rotation and no significant difference from that of a normal 
papillary muscle (Mirro, 2015). 
Pressures of Diastole and Systole: 
Diastole is defined as “the pressure exerted on the walls of the various arteries around the 
body in between heartbeats when the heart is relaxed”, and occurs at a normal range of 60-80 
mmHg in healthy adults. Systole is defined as “the measure of the amount of pressure the blood 
exerts on arteries and vessels while the heart is beating”. The average range in a normal healthy 
adult is 90-120 mmHg (American, 2015). 
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Pressure of Diastolic and Systolic after Myocardial Infarction: 
A study conducted hemodynamic monitoring in patients with acute myocardial infarction 
to better understand the pathophysiology of myocardial infarction and allowed an objective 
assessment of left ventricular filling pressure, cardiac output, and aortic pressure. The study 
included thirty-eight patients, aged 39 to 77 with acute myocardial infarction (conducted within 
48 hours of onset of symptoms). Results showed that the left ventricular end-systolic volume was 
125 +/- 41 ml/m2 compared to 82 +/- 10 ml/m2 in normal, healthy adults. The left ventricular 
ejection fraction 36 +/- 8% compared to 56 +/- 3% in normal, healthy adults. Overall, patients with 
acute myocardial infarction had significant increase in the left ventricular end-systolic volume and 
decrease in ejection fraction compared to those in normal hearts. The end-diastolic volume was, 
however, increased only in those with an elevated left ventricular filling pressure or decreased 
cardiac index (Rigo, 1974). 
Design Requirements and Functions  
 
For our device, insertion will occur from the outside of the heart wall and will be placed 
inside the papillary muscle. This will be done through port access surgery, allowing our device to 
be minimally invasive. Current devices are inserted through open heart surgery, which is very 
invasive compared to port access surgery. This will help decrease the recovery time for the patient, 
allowing them to return to their daily activities.  
The typical displacement of the papillary muscles after myocardial infarction is 2.5-5mm. 
The material chosen for our device will allow the papillary muscle to return to a position that will 
allow for proper closure of the mitral valve leaflets.  
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Our device needs to be durable because we want it to last the remainder of the patients’ life 
time. A problem with current devices are that they are a temporary fix and another surgery is 
needed 10 years later. Our device will be a permanent one-time surgery for the patient.  
We also want our device to be easy for the surgeon to use. Because current devices on the 
market have been used for so long, it could be difficult to introduce a new product if the surgery 
is more complicated than the current method.  
Functions 
 
The purpose of our device is to be minimally invasive. This will be accomplished through 
port access surgery. We also want this to be a permanent, one time surgery for the patient. Our 
device will be placed inside the papillary muscle of the left ventricle of the heart to reposition the 
muscle in a new orientation that will allow for proper closure of the mitral valve leaflets in order 
to eliminate mitral regurgitation after myocardial infarction.  
Specifications 
 
Specifications were determined for our device to ensure that it would function properly 
when placed inside the papillary muscle of the left ventricle.  
The first specification was that the device could not be longer than the papillary muscle 
itself, which is typically 13-19mm. We did not want to cause more damage to the heart, so the 
device needed to be smaller than the typical size of the papillary muscles. However, the device 
must also be long enough to enter the papillary muscle through the heart wall. The heart wall after 
myocardial infarction is typically 10-20mm. The final specification was that in order to reposition 
the papillary muscle, it needs to be within the range of 2.5-5mm, which is the typical displacement 
seen after myocardial infarction.  
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The device also need to be biocompatible by not damaging the biological environment it 
would be placed in. Fragility was also another specification when focusing on the mitral valve 
leaflets. The leaflets are very fragile so we had to ensure that our device could not cause tearing of 
the leaflets, leading to further complications. And our last specification was cost. We had to make 
sure we stayed within our budget and that our device did not cost more than current devices on the 
market. 
Important Industry Standards  
 
Industry Standards allow for regulation, legal liability, ethical research and development, 
clinical practice, and patient safety. Since our device falls under cardiovascular standards, it would 
be classified as a division three: medical/surgical device. Many of the regulations enforced by the 
FDA regarding medical devices are found in Title 21 Code of Federal Regulations Part 800 to Part 
1299. This involves device classification, 510 k clearance to market, pre-market approval (PMA), 
good manufacturing compliance (GMP) compliance, establishment registration, device listing, and 
medical device reporting (MDR). 
Conceptual Designs  
 
 After determining the requirements and functions for our device alternative designs were 
developed to solve the problem addressed by the initial client statement as well as the revised client 
statement.  
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Design 1: Webbed Polymer Coating 
  
Spider silk is becoming an attractive biomedical material 
used in tissue engineering applications. The interlocked webs add a 
greater attachment to the location it is placed (Figure 3). This was 
used as a design alternative because it could better withstand the 
conditions in the left ventricle. This design showed properties of 
interest such as, high-energy absorption rates, rupture 
elongation, and high strength (Table 3). The material would 
take aspects of an actual spider web and be coated with a polymer to make more elastic. This 
design would also allow for the papillary muscle to be not be removed because the webbing would 
be placed over the current dead muscle. This device would be used in the case that the papillary 
muscle has died, allowing for stable attachment sites. This attachment would make the surface of 
the papillary muscle rougher, which can lead to a more secure attachment.  
Table 3: Pros & Cons Design 1 
Pros Cons 
Use of Ideal Mechanical Properties from web Use of Staples in heart 
Use of Polymer Coating Polymer hard to locate 
 Invasive 
 Web could dislodge  
 Coagulation 
 
Figure 3: Webbed Polymer coating 
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Design 2: Surface Modification for Chordae Attachment 
 
If the chordae tendineae of the valve were to become 
detached from the papillary muscle, a design was created to 
reattach the chords. The surface of the papillary muscle will 
once again be roughened to allow for easier attachment (Figure 
4). The papillary muscle is dead in this method as well, and 
staples will be placed on the surface. The surface 
modification would be done to increase the surface 
roughness, increasing the amount of attachment. However, there has not been much research into 
this method, which makes this idea not as viable.   
Similarly, a table was created of this designs pros and cons (Table 4). 
Table 4: Pros & Cons Design 2 
Pros Cons 
Not as invasive Unknown Polymer to be used 
Increased surface area for attachment Not strong mechanically 
 Biocompatibility 
 
 
Design 3: “Silly Putty” Attachment 
 
 This design addresses the need to reattach the chordae tendineae or a dislocated papillary 
muscle. The premise of this idea is that at the end of the 
chordae, a portion of putty-like material will be placed 
so that the chordae could be securely attached in a new 
location (Figure 5). This design is a plus because of its 
strength and attachment properties, however this is a 
novel idea that has not been widely researched (Table 5).   
Figure 4: Surface modification of the dead papillary muscle. The 
dots represent the surface modification with a polymer string 
allowing for reattachment. 
Figure 5: The "Silly Putty" Idea for attachment 
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Table 5: Pros & Cons Design 3 
Pros Cons 
Versatility for each Patients Heart Attachment with material might be difficult 
Not as Invasive Biocompatibility 
 Proper Symmetry might be hard to come by 
 
Design 4: Attachment of Cardiac Cells to Surface 
 
 The fourth design explored the possibility of regenerating the papillary muscle. This design 
would seed the surface of the papillary muscle with stem cells to return the contracting function, 
in the case that it had died (Figure 6). The 
attachment of the cells would be achieved through a 
bonding method that would allow the cells to remain 
on the papillary muscle. However, after much 
research, it showed that this may not be a realistic 
solution. In a few studies, it showed that 
regeneration was only possible in <1 percent of 
papillary muscles and the rate decreased with increasing patient age. Due to this research, this idea 
is not feasible (Bergmann, 2009). Other studies used skeletal muscles in the heart, but led to failure 
due to the differences between the cell types (Marasco, 2008). Below is the table of the designs 
pros and cons (Table 6). 
Table 6: Pros & Cons Design 4 
Pros Cons 
Idea sounds nice of putting new cardiac cells Probably not as strong as thought 
Some function returns Such a minor amount of function 
 Question of how to stick the cells to surface 
 
Figure 6: Seeding Cells on Surface of Papillary Muscle for 
Returned Function 
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Design 5: “Suction Cup” Method 
 
In the fifth design a suction cup 
technique was explored to utilize the pressure 
changes between the systolic and diastolic 
phases of the heart for a mock leaflet (Figure 
7). The suction cups could be on both sides of 
the mitral valve or in the left ventricle. The 
leaflets are very fragile, so this idea is not the 
most feasible. It would most likely result in ripping or destruction of the leaflet. More research 
would have to be done on this technique. The figure to the right shows the two design modifications 
for the pressure ring around the valves on either side and the suction device on the papillary muscle. 
Below is a list of pros and cons (Table 7).  
Table 7: Pros & Cons Design 5 
Pros Cons 
Capitalize on Natural Pressures Might lead to misshapen heart 
No more leakage Valves too thin most-likely 
 Might cause more complications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: The Suction Cup Method/ Ring method. 
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Design 6: Full Replacement with Polymer 
 
A few designs were created that involved the removal of the dead papillary muscle. In this 
design the muscle would be completely removed and replaced 
by a biocompatible polymer (Figure 8). There were a wide 
range of different polymers, some were piezoelectric while 
others were conducting polymers. Upon further discussion, full 
removal of the papillary muscle was not ideal due to the 
amount of bleeding that would occur. Determining which 
polymer would be best depends on the mechanical properties of each polymer. The polymer would 
need to not lead to inflammation or coagulation on the surface, so coating this polymer with a 
protective covering or performing surface modification would be needed to ensure that it would 
not fail. The table below is the pros and cons list for this design (Table 8). 
Table 8: Pros & Cons Design 6 
Pros Cons 
No more dead papillary muscle Changes shape of heart 
Better mechanical properties Severe Bleeding 
Degradation factors? Not what the surgeon wants 
 Invasive 
Figure 8: The full replacement of the papillary muscle 
with a polymer attachment 
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Design 7: Insertion of Polymer Loop 
 
In this design the papillary muscle has died and is 
removed from the heart. A polymer will be attached to the 
ventricular wall and the mitral valve leaflets (Figure 9). 
Causing the angle of the leaflets to be changed to address for 
proper closure. The drawback to this design is that the leaflet 
may not support the polymer used for attachment (Table 9). 
Also if the polymer is attached by a loop, this could lead to 
increased blood volume.  
Table 9: Pros & Cons Design 7 
Pros Cons 
Not as invasive Valves too thin 
Creative Solution Idea, not actuality 
Tested. So it works for valve regurgitation Leads to more problems 
 
Design 8: Papillary Anchor 
 
 In this design the dead papillary muscle is used 
as an anchor for the chordae tendineae to be reattached 
(Figure 10).  It is assumed that the chordae tendineae is 
still attached to the mitral valve, which will allow for the 
chords to be reattached to the papillary muscle, or a 
biocompatible chord could be inserted that attaches. The 
papillary muscle would be used as the attachment site 
for the chords so that the leaflets close at an angle that decreases mitral regurgitation. Instron 
testing would needed to be done to decide which polymer would be best used.  Also surface 
Figure 9: Looped Polymer attachment 
Figure 10: Papillary Muscle Anchor Design 
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modification techniques and coatings would need to be incorporated to make the material more 
biocompatible (Table 10). 
Table 10: Pros & Cons Design 8 
Pros Cons 
Can mix use of current chordae with polymer Might not work 
Fixed to one location Not good under deformed heart 
 
Design 9: Velcro Design 
 
This design involved using a Velcro-like 
material for attachment of the chordae to the 
papillary muscle (Figure 11). The Velcro design 
would be executed through hooks and loops that 
create a secure system.  With this Velcro design, the 
attachment would be interchangeable depending on 
what angle the chords needed to be pulled in to 
establish proper closure of the mitral valve leaflets. This design would require a coating to make 
sure it is biocompatible and that there is no coagulation. The limitations to this are that it is not 
highly explored in research; so many trials would have to be performed to decide which material 
to use and how the device would be constructed (Table 11).  
Table 11: Pros & Cons Design 9 
Pros Cons 
Movable A lot of foreign material 
Strong Coagulation 
 
 
Figure 11: The Velcro Design 
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Design 10: Conducting Polymer Addition 
 
The tenth design included using a conducting polymer 
to allow the papillary muscle to contract. The polymer would 
receive signals from the nodes of the heart, allowing it to 
contract (Figure 12). A conductive polymer that was 
investigated was PTFE due to its high conduction and 
biocompatibility. Through the addition of PTFE, the 
papillary muscle would be able to contract, if it had died. 
However, through research it was discovered that a previous Major Qualifying Project Team 
researched using a conductive polymer for papillary muscle regeneration. Ultimately it was 
deemed too expensive and the results did not exhibit the same qualities as hypothesized. Although 
PTFE has high contractile properties, it was difficult for this polymer to regenerate the papillary 
muscle (Table 12).  
Table 12: Pros & Cons Design 10 
Pros Cons 
Contracts Too expensive 
Biocompatible Timed contractions 
 Displacement not good. 
 
Design 11: Regenerate a New Papillary Muscle 
 
 A new papillary muscle would be able to be 
regrown through the use of induced pluripotent stem cells 
(Figure 13). This would be done in the case of papillary 
muscle death. The stem cells would be cultured to contract 
in order to give this function into the tissue engineered 
papillary muscle. This new papillary muscle would Figure 13: Regeneration of a Papillary Muscle  
Figure 12: The PTFE polymer model 
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then be inserted into the heart in place of the dead muscle.   Through research, it was found that 
the cell properties, especially in cardiac cells could be altered depending on what surface the cells 
are grown on. Culturing a large quantity of cells to contract simultaneously and finding a material 
to seed these cells on, that have similar properties to those of the papillary muscle proves to be a 
challenge (Table 13).    
Table 13: Pros & Cons Design 11 
 
 
Design 12: Collagen Cross-linked Hydrogel with Cardiac Cells 
 
 Through research on hydrogels, it was found 
that seeding of cells on crosslinked collagen hydrogels 
can make this biocompatible. When placed in the body 
the cells can help regenerate the function of a dead 
papillary muscle, and also fix the displacement (Figure 
14). Cardiac cells can be used because they will exhibit 
the least foreign body response (Table 14).  
Table 14: Pros & Cons Design 12 
Pros Cons 
Biocompatible Hydrogels Properties 
Good Mechanical Properties  
Movable.  
 
Pros Cons 
Full function, new muscle Fantasy vs reality 
Contractile Properties. Muscle Failure 
 Poor Mechanical Properties 
Figure 14: Hydrogel - Collagen Cross-link design 
47	
	
Design 13: Annuloplasty Ring Idea 
 
 This design is based off of current patents and 
devices out on the market today. To help reduce 
turbulence in blood flow created by the annuloplasty ring, 
a saddle horn shape would be incorporated on the design 
(Figure 15). A saddle horn would be an indent on the 
circle to make it more like the normal shape of the mitral valve. The ring would be created out of 
a durable polymer that will help correct the position of the heart valve back to its original shape. 
The design would allow the mitral valve to maintain the natural shape, function and movement. 
Although the gold standard for correcting mitral regurgitation are annuloplasty rings, incorporating 
the saddle horn would cause further complications (Table 15).  
Table 15: Pros & Cons Design 13 
Pros Cons 
Proven that it fixed mitral regurgitation Makes blood flow faster 
Can be minimally invasive. Not innovative enough 
 Solves one problem, leads to more 
 
Design 14: Retractable Suture Method 
 
This design was based on the concept of 
a retractable ID badge (Figure 16). It would 
allow for a string to be pulled to a particular 
length and excess string to be retracted into the 
base. This function makes the device applicable 
for different heart geometries. The CAD design 
is in Figure 15 It would be a two tier system to 
allow for the device to be pulled in two different directions. Surgeons would use MRI data or other 
Figure 15: The Annuloplasty Ring Design 
  Figure 16: SolidWorks Drawing for Retractable ID Design 
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forms of digital imaging to know where to suture the string to the myocardial wall. A nitinol spring 
would be placed inside the base and attach to PTFE string, allowing the string to be pulled out to 
a certain amount. PTFE is the ideal polymer for this device because it is a synthetic fluorocarbon 
polymer that is currently being used for different cardiovascular applications. PTFE has low 
surface free energy and hydrophobicity, which prevents particles from sticking to its surface.  The 
use of PTFE is the polymer of choice because it has been very successful with other heart 
applications that have been utilized. In Figure 16, the base of the device is placed on the outside 
of the myocardium wall. This idea was introduced after realizing the limited surface area offered 
by the papillary muscle making it near impossible to create a device large enough to incorporate 
everything we wanted. A Pros and Cons list is in the tables on the next page (Table 16). 
Table 16: Pros & Cons Design 14 
Pros Cons 
Versatility for each Patient's Heart Device might be too small on tip of papillary 
muscle 
Not as Invasive Potential Blood Clotting in heart 
Innovative Design Might be hard to maneuver around the chordae 
 
 
Design 15: Nitinol Cantilever Design 
 
 The incorporation of a Shape Memory Alloy, 
Nitinol, has been a common component in other 
cardiovascular devices. Nitinol is a very durable and 
strong material that can be treated to change shape at 
different temperatures (Figure 17). The use of nitinol as 
a cantilever is beneficial because it is contained within 
the papillary muscle, eliminating the need for sutures or 
other aspects that could cause further damage to the infarcted heart. The Nitinol can be bent or 
Figure 17: Nitinol Cantilever Design 
49	
	
trained at the angle necessary to return the papillary muscle to its original position. The insertion 
of this device will also be minimally invasive (Table 17).  
Table 17: Pros & Cons Design 15 
Pros Cons 
● Durable ● If train the nitinol to the wrong 
geometry, it is difficult to take back out 
● Minimally invasive ● Possibility of poking out of the 
papillary muscle/cutting the muscle 
● Easily shaped to fit whatever geometry 
we need 
● It could not move the muscle at all 
● High strength ● Possible toxic wear particles 
● Coat with a material to minimize 
chance of cutting through the muscle 
● If train the nitinol to the wrong 
geometry, it is difficult to take back out 
 
 Design 16: PTFE String through Heart  
 
 This design inserts a string of PTFE through the papillary muscle with the use of a 
minimally invasive procedure such as thoracoscopic surgery 
(Figure 18). This design will allow for the PTFE string to 
exit from the apex of the papillary muscle and it will be 
pulled in the direction that will regain proper closure of the 
leaflets. The PTFE adds flexibility to the device, making it 
easier to move the muscle in the desired direction. The PTFE 
will then be sutured to the heart wall in the location of the 
needed vectors. When sutured to the wall, the string will have 10% slack to account for length 
changes during the cardiac cycle.  Majority of the movement of the papillary muscles occurs from 
repositioning at the apex, so our device is ideal for this function (Table 18).  
 
 
Figure 18: PTFE String Design 
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Table 18: Pros & Cons Design 16 
Pros Cons 
● PTFE is used in many cardiovascular 
applications so it won’t be rejected 
● Cost 
● Easily adjust to the different heart 
geometries 
● Only account for geometry shape 
changing at the top of the muscle 
● Room to account for error right away ● Blood clots 
● Wont interact with chordae tendons ● Suturing to a weakened heart wall- will 
that have detrimental effects? 
● Slack on wire to account for change in 
volume during systole and diastole  
● In a device were you would need to 
know the exact vectors, doctors may be 
more inclined to go off of their own 
knowledge and estimate suturing 
visually rather than MRI 
 ● Account for pressure of fluids, 
anatomical structures around the 
papillary muscle, 
 ● Worry about how it will pull out of the 
papillary muscle so it’s not  entangled 
in the chords 
 
Alternative Designs 
Many designs were created that met the needs of the client in order to reposition the 
papillary muscle to its original position after displacement through myocardial infarction. This is 
done to eliminate mitral regurgitation, occurring from improper closure of the mitral valve leaflets. 
However, many of the designs had large amounts of complications associated with their functions. 
Through further research, meetings with our advisor, and defining our client statement we 
developed a final design that will be tested as our papillary muscle repositioning device. 
Many of the preliminary designs were not used because they did not fully address the need. They 
may have interfered with the chordae tendineae, or attached to the mitral valve leaflet making it 
weaker and more prone to prolapse. Below are the pros and cons for each of our alternative designs. 
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Design 1: Webbed Polymer Coating 
 
Table 19: Pros and Cons Design 1 
Pros Cons 
Use of Ideal Mechanical Properties from 
web 
Use of Staples in heart 
Use of Polymer Coating Polymer hard to locate 
 Invasive 
 Web could become intertangled or dislodged 
 Coagulation 
 
Design 2: Surface Modification for Chordae Attachment 
 
Table 20: Pros and Cons Design 2 
Pros Cons 
Not as invasive Unknown Polymer to be used 
Increased surface area for attachment Not strong mechanically 
 Biocompatibility 
 
Design 3: “Silly Putty” Attachment 
 
Table 21: Pros and Cons Design 3 
 
Pros Cons 
Versatility for each Patients Heart Attachment with material might be difficult 
Not as Invasive Biocompatibility 
 Proper Symmetry might be hard to come by 
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Design 4: Attachment of Cardiac Cells to Surface 
 
Table 22: Pros and Cons Design 4 
Pros Cons 
Idea sounds nice of putting new cardiac cells Probably not as strong as thought 
Some function returns Such a minor amount of function 
 Question of how to stick the cells to surface 
 
 
Design 5: “Suction Cup” Method 
 
Table 23: Pros and Cons Design 5 
Pros Cons 
Capitalize on Natural Pressures Might lead to misshapen heart 
No more leakage Valves too thin most-likely 
 Might cause more complications 
 
Design 6: Full Replacement with Polymer 
 
Table 24: Pros and Cons Design 6 
Pros Cons 
No more dead papillary muscle Changes shape of heart 
Better mechanical properties Severe Bleeding 
Degradation factors? Not what the surgeon wants 
 Invasive 
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Design 7: Insertion of Polymer Loop 
 
Table 25: Pros and Cons Design 7 
Pros Cons 
Not as invasive Valves too thin 
Creative Solution Idea, not actuality 
Tested. So it works for valve regurgitation Leads to more problems 
 
 
Design 8: Papillary Anchor 
 
Table 26: Pros and Cons Design 8 
Pros Cons 
Can mix use of current chordae with 
polymer 
Might not work 
Fixed to one location Not good under deformed heart 
 
Design 9: Velcro Design 
 
Table 27: Pros and Cons Design 9 
Pros Cons 
Movable A lot of foreign material 
Strong Coagulation 
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Design 10: Conducting Polymer Addition 
 
Table 28: Pros and Cons Design 10 
Pros Cons 
Contracts Too expensive 
Biocompatible Timed contractions 
 Displacement not good. 
 
Design 11: Grow a New Papillary Muscle 
 
Table 29: Pros and Cons Design 11 
Pros Cons 
Full function, new muscle Fantasy vs reality 
Contractile Properties. Muscle Failure 
 Poor Mechanical Properties 
 
Design 12: Collagen Cross-linked Hydrogel with Cardiac Cells 
 
Table 30: Pros and Cons Design 12 
Pros Cons 
Biocompatible Hydrogels Properties 
Good Mechanical Properties  
Movable  
 
After eliminating the above ideas. Two more were established; PTFE String through the 
Papillary Muscle and Nitinol Cantilever. Both designs are minimally invasive options for papillary 
muscle readjustment. The devices will be inserted through Thoracoscopic surgery and enter the 
heart through the heart wall. In Thoracoscopic surgery, the procedure is done through small holes 
55	
	
on the right side of the patient’s chest. This surgery is a benefit because the patient does not have 
to get their breastbone split, resulting in a quicker recovery time. 
PTFE String through the Papillary Muscle 
 
The PTFE string through the Papillary Muscles inserts the PTFE string through the heart 
wall and into the papillary muscle. The wire will be pulled out from the edge of the papillary 
muscle closest to the apex, to not interfere with the chordae tendineae. From there, the string will 
be pulled in the proper vector direction to account for the displacement of the papillary muscle and 
return to its original position. The string will then be sutured to the heart wall. 
Advantages to this device are that Polytetrafluoroethylene (PTFE) is the main material used 
and it has been used widely in cardiovascular applications. PTFE is currently used as sutures for 
repair of the mitral valve in myxomatous disease and it has also been used in surgery for anterior 
and posterior leaflet prolapse. PTFE is also used as the material for implantable prosthetic heart 
valve rings (Jaganathan, 2014). Another advantage of this device is that because it is a string, it 
can easily adjust to the different heart geometries of each patient. When patients hearts infarct, the 
papillary muscles will not all be displaced in the same manner, making it hard to adjust from the 
papillary muscles. Another advantage is because it is being implanted by port insertion, once it is 
in place it does not become permanent until it is sutured to the heart. So if the doctor had to move 
the papillary muscle a few centimeters in a different direction, the device allows for this to occur. 
Another advantage is that through further research this device could be modified to incorporate 
the use of fibrin microthreads seeded with contracting cells to aid in making this a more 
biocompatible device. 
There are a few drawbacks to this device that include the possibility of blood clots on the 
exposed string. Because a foreign particle is being added to the heart, there is a higher risk of blood 
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clotting or disrupting the flow of blood through the heart. Also because the heart wall has been 
slightly compromised due to the reshaping from the myocardial infarction, there could be further 
complications in suturing the PTFE string to the heart wall. This device is very dependent on 
following the vectors received from MRI in order to know the position of readjustment. However, 
doctors may be more inclined to use their own knowledge when performing the surgery instead of 
following the guidelines. Another drawback to this device is that it only moves the papillary muscle 
at the tip, it does not adjust the shape at the base or middle of the muscle. Moving the entire 
papillary muscle will result in more movement versus just adjusting the tip of the muscle. 
Nitinol Cantilever 
 
The second design is a nitinol cantilever that will also be inserted through the papillary 
muscle by port insertion. The nitinol wire will be designed so that its shape moves the papillary 
muscle back to its original position. The wire will remain inside the muscle and force movement 
internally. 
There are many advantages to this design, one being the high strength of nitinol. This 
strength will cause enough force to allow the papillary muscle to move back to its original position. 
This design is also minimally invasive because of the use of port insertion. This device will also 
remain inside the papillary muscle, avoiding interference with other sections of the heart. Because 
nitinol is very easy to train, it can be formed into any shape needed for proper movement of the 
papillary muscle, which will allow for easier processing. The transformation temperature of nitinol 
is normally 30°C, which is a bit lower than body temperature. In order to avoid the nitinol wire 
forming shape before proper insertion, it can be constrained by a retractable sheath or other 
material (Stoeckel, 2003).  Nitinol is also a very durable material so it will be able to last in the 
heart for a long period of time.   
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There are a few constraints associated with this device as well. A major problem will be in 
the training and processing of the nitinol wire. It will have to be trained with the exact geometry 
needed to move the papillary muscle back to its original position. If it is not, it will difficult to 
remove the wire from the patient and retrain it to another position. If this were to occur, an entirely 
new wire would have to be created, which causes the price of the device to increase. Another 
possible issue with this device is the wire cutting the papillary muscle, or creating a hole by sticking 
through the muscle. The wire will have to be developed so that it contains no sharp ends that could 
cause this damage. Another concern is that this device may not be strong enough to move the 
papillary muscle without other assistance. The Young’s Modulus of nitinol is between 28 - 40 GPa 
when in the martensitic phase and around 83 GPa when in the austenite phase (Johnson, 2015). 
And because nitinol is a metal alloy made from nickel and titanium, toxic wear particles are a 
concern. Also patients could be allergic to the nickel wear particles. 
Final Design 
 
Table 31: PTFE String through Papillary Muscle Pros and Cons 
Pros Cons 
PTFE is used in many applications Only accounts for shape changing at top of 
muscle 
Easily adjust to the different heart geometries Possible blood clotting on exposed string 
Room to account for error  Suturing to a weakened heart wall 
10% slack to account for change in volume 
during systole and diastole 
Could cause turbulence of blood flow 
Could add contractile cells to PTFE string Possible entanglement with chordae tendineae  
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Table 32: Nitinol Cantilever Pros and Cons 
Pros Cons 
Durable Material  Very specific shape geometry needed to move 
papillary muscle 
Minimally invasive  Could protrude out of papillary muscle  
Easily shaped to specific geometry  Could not move the papillary muscle  
High elastic modulus  Possible toxic wear particles  
 
After creating the pros and cons list for both the PTFE String Through the Papillary Muscle 
design and the Nitinol Cantilever design, we chose our final design idea to be the Nitinol Cantilever 
design. We as a group decided to use Nitinol as our cantilever material for multiple reasons. Nitinol 
is a shape memory alloy with great mechanical properties. Important factors to consider when 
choosing our material was its biocompatibility, since it would be placed in the heart, as well as its 
mechanical properties and whether it would be able to withstand the forces and pressures of the 
left ventricle. The Ultimate Tensile Strength of Nitinol when it is fully annealed is 895 MPa. This 
value is much higher than the forces and pressure the heart will exert on the material making it an 
ideal candidate to be used for our device. Nitinol has “a passive titanium oxide layer which protects 
the base material from corrosion and nickel release”, by removing Ni atoms from the surface of 
the material (Nitinol, 2015). Out of all the shape memory alloys on the market today, NiTi has the 
best superelasticity, biocompatibility, corrosion resistance, and overall engineering properties. 
Other alloys such as copper-aluminum-nickel, copper-zinc-aluminum, and iron-manganese-silicon 
are less stable and more brittle than Ni-Ti, have limited shape memory strain, and lack ductility. 
Under normal conditions, nitinol has an infinite shelf life and is not affected by humidity changes 
59	
	
(Nitinol, 2015). Additionally, characteristics that make NiTi a standout material for our application 
is its hardness, impact toughness, high fatigue strength, machinability, and naturally low density. 
Feasibility Study 
 
Preliminary tests were performed to test the mechanical strength of the different chordae 
tendineae in a pig’s heart. These values would be compared to that of the literature. For the first 
experiment, we isolated the papillary muscles of the left ventricle and prepared them for testing. 
This can be seen in Appendix A.  We wanted to test the difference in tensile strength between a 
papillary muscle with all of the chords attached, versus a papillary muscle with only one chord. 
Tensile testing was created using Bluehill software, however, due to time constraints we were only 
able to test the papillary muscle with all of the chorea attached. The results of the testing were 
compromised due to slippage, so values from the literature were used to create our designs.   
More anatomical features were observed in pig hearts to test if our design ideas could be 
applied in vivo. Heart dissection videos were watched to understand the proper procedure for 
cutting into the left ventricle while leaving the mitral annulus intact. The design idea of inserting 
the device through the heart wall into the papillary muscle was tested to see if it was feasible or 
not. We viewed the thickness of the ventricle as well as the mobility of the papillary muscle 
through insertion of a zip tie. The zip tie was used to move the muscle in all directions. The zip tie 
was then inserted through the wall into the papillary muscle and moved. By testing the movement 
of the papillary muscle with the zip tie, it validated our final design of moving the papillary muscle 
with a Nitinol cantilever. 
The use of Finite Element Analysis (FEA) was researched to see whether it would be useful 
for our project. FEA is a computer modeling software that helps predict what a product will do 
under real world situations. The finite element model is a system of points, or nodes. These nodes 
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are what create the shape of the design. The finite elements are 
connected to these nodes and this is what forms the finite element 
mesh. This mesh contains the material and structural properties 
of the model and this determines how it will react in certain 
conditions (Siemens, 2015). Some of the situations that could be 
modeled with FEA that are applicable to our project are forces, 
fatigue, fluid flow and heat transfer. There are many different 
softwares that are available for the analysis of these computer meshes such as “Abaqus” and 
“Ansys”. 
At Worcester Polytechnic Institute, Professor Sergey Makarov developed a highly detailed 
digital model of the human body, “The Living Human”. This FEA model has the capabilities to be 
used by doctors to help them conduct medical experiments or procedures before performing them 
on live patients. We wanted to utilize this project to model the heart of a patient who suffered from 
myocardial infarction. An advanced model of Finite Element Analysis was done by Dassault 
Systemes called the “Living Heart Project”. The mesh system that they used is shown in Figure 19 
and the model was specified for an enlarged left side of the heart. We hoped to use this type of 
system to determine if our device would function in the heart. However, upon meeting with 
Professor Makarov, he suggested not using this system due to time constraints and lack of the 
proper computer science knowledge to develop this type of FEA model. Professor Makarov did 
mention the use of either “Comsol” or “Ansys” for our project.   
 
 
 
Figure 19: Finite Element Mesh Model 
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Design Calculations  
 
The following chart displays the calculations researched and solved for to determine the 
dimensions are device should contain, forces it should withstand, and amount of angular 
displacement it should account for.  
Table 33: Design Calculations 
Average Length of Anterior Papillary Muscle 20 years old or younger: 1.53 +/- 0.34 cm 
21 to 40 years old: 2.05 +/- 0.39 cm 
41 to 60 years old: 2.01 +/- 0.25 cm 
Average Length of Posterior Papillary Muscle 20 years old or younger: 1.33 +/- 0.34 cm 
21 to 40 years old: 1.95 +/- 0.89 cm 
41 to 60 years old: 1.81 +/- 0.76 cm 
Displacement Length of Anterior Papillary 
Muscle after Myocardial Infarction 
3 +/- 2 mm to the left perpendicular to the tip, 1 
+/- 1 mm down 
Displacement Length of Posterior Papillary 
Muscle after Myocardial Infarction 
7 +/- 3 mm to the left perpendicular to the tip, 8 
+/- 5 mm at 45 degree angle of the tip, 1 +/- 1 
mm down 
Average Strain on Papillary Muscle from 
Systole to Diastole 
10 % 
Maximum forces on the papillary muscle at 95 
mmHg 
Mean force: 4.1 +/- 9 N 
Anterior Papillary Muscle: 5.3 N 
Posterior Papillary Muscle: 5.1 N 
Angular Displacement Mean angular displacement: 3.2 degrees 
Range: 0-7 degrees 
Left ventricular end-systolic volume for 
patients who have experience myocardial 
infarction 
125 +/- 41 ml/m2 
Left-ventricular ejection fraction for patients 
who have experienced myocardial infarction 
36 +/- 8 % 
62	
	
 
Modeling  
 
Models of our device were created with the use of SolidWorks. Figure 20 below shows the 
cantilever papillary muscle repositioning device.  This modeling was used to determine the forces 
that would be on our device from the chordae tendinae, papillary muscle itself, as well as the heart 
wall.  
 
 
Figure 20: Cantilever Papillary Muscle Repositioning Device in SolidWorks 
 
Preliminary Data 
 
All testing was performed in vitro on pig hearts to allow for a visual of the papillary muscle 
movement. However, testing with this method had limitations. Cutting the heart in half to isolate 
the left ventricle did not allow for an accurate visual of how the muscle react in vivo. An attempt 
to solve this problem was done by purchasing a camera that could be inserted into the 
aorta/pulmonary valve of a pig heart and insertion of the nitinol could be done in a full heart with 
the use of the camera. However, during testing we discovered our camera did not have a brightness 
adjustment nor an attachable flashlight, so a proper image of the papillary muscle was hard to 
capture. Another difficulty was knowing the exact location of where to place the nitinol without 
having a proper visual.  
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 We began our experiments with determining which size of nitinol wire would show the 
greatest movement of the papillary muscles. Our project accounts for the displacement after 
myocardial infarction; typically the papillary muscle moves 2.5-5 mm towards the heart wall from 
its original position when in an infarcted state. We took measurements of the original distance 
between the anterolateral papillary muscle and the posteromedial papillary muscle in the left 
ventricle before and after the insertion of nitinol. The nitinol was inserted into the posteromedial 
papillary muscle and the displacement when the muscle was moved towards the heart wall and the 
anterolateral papillary muscle was measured. This was done to test if the muscle could be moved 
enough to overcome the amount of displacement experienced after myocardial infarction. The 
original distance from the two papillary muscles (center-to-center) of our experimental heart was 
3.5 cm.  
We had ordered nitinol with a range of thickness. This resulted in nitinol of 0.025cm, 
0.051cm, and 0.076cm of thickness. When inserting the nitinol of 0.025 cm, there was no 
movement in either direction, towards the anterolateral papillary muscle or the heart wall. The 
0.051cm thick nitinol had a displacement of 0.3cm when moved towards the heart wall and 1cm 
when moved towards the anterolateral papillary muscle. The 0.076cm had a displacement of 0.5 
cm when moved towards the heart wall and 1.2 cm when moved towards the anterolateral papillary 
muscle. This validated that all thicknesses except the 0.025cm nitinol, could move within a range 
that would account for the displacement of the papillary muscle after myocardial infarction. The 
0.076 cm nitinol was chosen for our final design because it had the largest degree of movement 
and could correct for the largest amount of displacement. 
 To test whether the nitinol wire should be straight or curved, we inserted the different 
shaped nitinol wires into the papillary muscle to determine which had the best movement. The 
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nitinol was trained to have a curved shape by using pliers. This curved wire was then placed in 
boiling water of 276.6°F. When the wire was removed, it was quenched by being placed in cold 
water allowing the wire to keep its shape. After completing this experiment, we concluded that the 
trained curved nitinol was not as effective as the straight nitinol. Insertion of the curved nitinol 
into the papillary muscle was difficult due to the head of the wire would protrude out the side of 
the papillary muscle instead of reaching the tip of the muscle. When the nitinol was successfully 
inserted, little to no movement was seen. The 0.051cm curved nitinol did not move the papillary 
muscle. While the 0.076cm curved nitinol only allowed for back movement of the papillary 
muscle, due to how the curved portion of the wire was inserted into the muscle. 
V. Design Verification 
	
 Myocardial infarction generally causes a displacement of the papillary muscle of about 2.5 
- 5 mm from its original position. Ideally, our device would be able to move the papillary muscle 
to allow for proper closure of the leaflets. Through simulations and calculations, the length of the 
device needed to move the papillary muscle as well as the choice of material would be confirmed.   
AutoDesk ForceEffect and Calculations 
 
In order to ensure that our device was feasible, hand calculations, along with computer 
simulations were used. For the hand calculations, free body diagrams and cantilever equations for 
a distributed force and a specific force were used. The hand calculations were also supplemented 
by Autodesk ForceEffect to create a comprehensive free body diagram of the system as seen in 
Figure 21. These steps are important to help verify the results of our device and compare them to 
the computer models. 
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Figure 21: The Free Body diagram of the device when inserted into the heart with its forces. The F1 is from the chordae tendinae 
on the papillary muscle, F2 and F3 is the forces being exerted from the heart wall, and the distributed force is that being exerted 
on the papillary muscle. 
This free body diagram was paired with the hand calculations to help lead to the proper 
equations. The device is a cantilever rod that is fixed on one end. In the heart, there are different 
forces that are based on the cardiac cycle. For the analysis, it was assumed that the device was in 
the diastole phase because it will present us with the data when the heart is at rest. The heart does 
exhibit variation in pressures during the different cycles. The equations below represent the initial 
equations that were used in our analysis. 𝑣"#$ = 	 '()*+,       (1) 𝑣"#$ = 	 -(./+, 							 (2) 
The equations are for each of the different forces that are being exhibited onto the device. Equation 
1 is related to F1 and its isolated load on the end of the device. Equation 2 is related to the 
distributed force across the device in the heart. For a more exact breakdown of the calculations, 
please refer to Appendix A. The solutions were then totaled to determine the deformation of the 
nitinol in the device. Table 1 below shows a summary of what the forces values that were used for 
the different forces in the calculations.   
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Table 34: The list of values used for the calculations 
Force Value [units] 
Chordae Tendinae Force (F1) 4.1 N 
Papillary Muscle Force (Q1) 5.1 N or 3834 N/m 
Forces from Heart Wall (F2, F3) 5 N 
 
 Autodesk ForceEffect outputs different outcomes from the free body diagram that was 
created. These values are shown in Table 35 below. The values from this simulation verified the 
hand calculations and brought us to ask what the added moment would be. This simulation could 
also take into account the forces from the heart wall, adding variation in the results. Displacement 
is the most important calculation because it determines the amount of movement our device will 
be able to have on the papillary muscle.  
Table 35: Autodesk ForceEffect Outputs 
Output from Program Value [units] 
Shear Force 9.2 N  
Moment 25.7 N/m 
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SolidWorks Nitinol Material Model Simulation 
 
 Along with the calculations, SolidWorks15 was used to create the material simulation of 
our nitinol model. As seen in Figure 
22, the same numbers were used 
from the hand calculations and this 
showed a three dimensional model 
of the change that the device would 
undergo. The nitinol does have a lot 
of potential to deform if needed 
which is partly due to its Shape 
Memory Alloy effects. It was 
expected that the nitinol would deform a lot, but the model showed a higher degree of movement 
than expected. The ideal range of movement would be 2.5 - 5 mm to match that of the papillary 
muscle displacement after myocardial infarction. 
 The SolidWorks nitinol material model is based off the use of Lagrangian formulas. It uses 
nitinols different finite strains and its loading and unloading potential, all while maintaining its 
shape and properties. The model also takes into effect the logarithmic strains, along with the 
Kirchhoff stress which then goes into a matrix that demonstrates the transformed material. 
SolidWorks wanted to have the ability to show how the nitinol would behave without the 
permanent deformations that would occur from other materials. This model helps show the 
superelastic properties of the nitinol and provide a visual of them. Other factors like the yield 
criterion and the flow rule were taken into effect to help show the phase changes. 
Figure 22: 14mm length nitinol showing a displacement of 2.7mm 
 
68	
	
The green arrows show where the cantilever beam would be fixed which is under the 
assumption that would be contained by the forces of the heart wall, this will be about 1cm of the 
nitinol cantilever device. The purple arrows show the different forces that would be put onto the 
device from the chordae tendineae and the papillary muscle. The different simulations were 
conducted to obtain the length of the nitinol that would be inserted into the papillary muscle. The 
minimum and maximum length was obtained by the results of the graph. The displacement 
diagram in Figure 22 shows the that the 14 mm nitinol wire would have a displacement of about 
2.7 mm which is in the desired range of 2.5-5mm. 
A diagram was also run to get a maximum displacement closer to the 5 mm. The diagram 
in Figure 23 shows that the amount of movement was about 4.9 mm as a result of a 15.5mm nitinol 
wire.  
 
 
Before the simulation was run, the rod was placed horizontally and the end was where the 
floating purple arrows are located. The total amount of deformation is greater than the total amount 
needed for the device.  An example of this would be on the 14 mm device shown in Figure 24. 
Figure 23: 15.5mm length nitinol showing a displacement of 4.9mm 
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Figure 24: The results for the 14 mm cantilever device compared to the device. Note: this is not to scale. 
 
 The one setback about the SolidWorks model was that some of the numbers are not 
accurate. Another setback was that the simulation could not be conducted on the whole assembly, 
which is one the forces are focused solely on the nitinol wire. This would eliminate the forces from 
the heart wall which would help counteract some of the deformation and require less movement. 
The simulations are also a check to ensure that the devices work in the body the way that we intend 
them to. Again, the SolidWorks simulation only accounted for the part inserted into the papillary 
muscle. 
The benefits of having a range of values that the simulations produced helped verify that 
the device is customizable. Based on the amount of papillary muscle displacement of each patient, 
the length of the device could be modified. The adaptability of the device makes it more 
marketable. The ability to have the device customizable will allow more patients to benefit from 
our device.  
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VI. Final Design Validation 
 
 Our final device was a cantilever papillary muscle repositioning device. The SolidWorks 
drawing shows the isometric view of the 
device in Figure 25.  
 This design would be inserted 
through the outside of the heart wall, 
allowing for a larger surface area. This also 
avoids the entanglement issues that would 
occur on the internal devices that were in 
the left ventricle. This device would stay 
internal of the papillary muscle so there would not be interaction with the device and the fluids 
inside the heart. The device would be sutured to the heart wall on the supportive base to allow for 
more stability.  
The bill of materials, along with the exploded view is shown in the SolidWorks drawing. This bill 
of materials outlines the parts of our final device shown in Figure 26.  
 
Figure 25: SolidWorks Isometric View of Papillary Muscle 
Repositioning Device 
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There are five main components of the device which include: the nitinol rod, the silicone base, 
the stainless steel base, the cap, and the screws. The nitinol rod was trained straight for easier 
insertion and improved movement. The length of this rod 
depends on the displacement of the papillary muscle due to 
myocardial main parts. The silicone rubber component has the 
ability to conform to the geometry of the heart wall allowing for 
a more secured placement upon insertion. And the stainless steel 
base has been used in other cardiovascular applications, such as 
annuloplasty rings. The last component is the stainless steel 
cap that helps secure the nitinol in place. This portion ensures the stability of the device and 
prevents the nitinol from losing its position during the cardiac cycle.  
Figure 26: Bill of Materials for Device 
Figure 27: Placement of Nitinol 
Cantilever Device in Papillary Muscle 
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 Our device would be inserted into the heart via port access surgery which would meet the 
objective to be minimally invasive. The length of the nitinol rod for each device would be 
determined based off of the CT scans and the amount of displacement of the papillary muscle. The 
device will be inserted at the proper angle that will account for the amount of displacement that 
occurs after myocardial infarction. Figure shows the proper insertion of the nitinol cantilever in 
the papillary muscle. Once the device is in place, the base of the device will be sutured to the heart 
wall for security.  
VII. Discussion 
	
When presented with the initial client statement, our group came to the realization that although 
the initial solution was to use fibrin microthreads, that was not the aim of the client statement. By 
going through the design process and evaluating what the client was asking, we determined that 
the client was not focused on the use of fibrin microthreads but wanted a solution to eliminate 
mitral regurgitation after myocardial infarction. Once we were able come up with a revised client 
statement that we felt better answered the problem being asked of us, we were able to refine our 
list of functions, objectives, and constraints.  
 The decision to choose Nitinol was based on in depth investigation of biomaterials used in 
cardiovascular applications as well as which material best suited the needs of our device. We 
needed the material to move the papillary muscle 2.5-5mm as well as adhere to the length of both 
the papillary muscle and heart wall so it would not protrude out into the ventricle and cause more 
problems. In vitro experiments where nitinol was inserted into the posterior-medial papillary 
muscle of the left ventricle of a porcine heart and manually maneuvered towards the anterolateral 
papillary muscle and the heart wall were executed. This was done to get the maximum 
displacement the material would allow to determine if nitinol would successfully work in moving 
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the papillary muscle within the typical displacement range after myocardial infarction. Stainless 
steel and silicone rubber were suitable materials for the base because of stainless steels uses in 
cardiovascular applications as well as silicones ability to conform to the geometry of the heart wall 
allowing for a more secured placement upon insertion.  
  The SolidWorks material model simulation was used to determine how the material would 
displace when placed in vivo. The forces from the papillary muscle, chordae tendinae, and stresses 
acting on the heart wall from contractions were derived from literature and applied on the 
cantilever beam. These forces were applied to the solidworks model of the nitinol rod in order to 
determine the required length needed to achieve the typical displacement experienced by the 
papillary muscle post myocardial infarction. Taking the unique properties of nitinol into effect 
helped give a more accurate example of what the Shape Memory Alloy would do in vivo to show 
the amount of movement that would occur. The model only showed the portion of the nitinol that 
was in the papillary muscle so 10 mm had to be added to the final length of each of the lengths to 
account for the uniform forces from the heart wall. The minimal displacement of 2.7 mm was 
achieved with a length of 14 mm. The maximum displacement of 4.9 mm was achieved with a 
length of 15.5 mm. This opens up many possibilities to make our device customizable based off 
of the CT scans taken of the patient, showing how much displacement their papillary muscle 
experienced. Having this minimally invasive option also be customizable will make it easier for 
the surgeon to efficiently insert our device. Combining these results, with the hand calculations, 
demonstrated our device could reposition the papillary muscle to a location that accounts for the 
displacement seen after myocardial infarction.  
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ABET Criteria 
 
Economics  
 The current cost of a mechanical or biological heart valve is between $5,000 and $7,000 
(Pick, 2010). Economists have measured the economic value of improved health and longevity 
and determined that there is an enormous return on investment for patients, especially the elderly, 
who receive aortic valve replacements. However, the initial investment is extremely cost 
consuming. In the United States, the average cost of heart valve replacement surgery is $137,184 
and this includes materials for the valve (man-made if it is mechanical and made from animal 
tissues for biological valves), as well as anesthesia.  
Our device will b e  inserted through port access surgery, a minimally invasive surgery 
that allows for decreased recovery time. For 24 hours, the patient cannot drive a car, drink alcohol, 
or make important personal decisions. After a week the patient should be able to resume their 
usual activities (UW Medicine, 2015). Because time needed to recover is decreased, the 
patients’ hospital stay will be decreased as well.   
Current mechanical heart valves will put a patient on anticoagulants for the remainder 
of their life. And biological heart valves will require a replacement surgery about 10 
years later. Our device will only require a one-time surgery with no need of post medications. 
Environmental Impact  
 
The material chosen for this device are biocompatible meaning there will be no damage to 
the body when placed in vivo. Nitinol is about 50% Ti, so molten Nitinol is very reactive and has 
to be processed in a vacuum. Vacuum induction melting and vacuum consumable melting are very 
commonly used. To machine nitinol, conventional methods such as milling, turning and drilling 
can be used. However, these methods can be difficult and cause tool wear. That is why carbide 
tools with chlorinated lubricant are recommended (Wu, 2002). 
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The base of our device is formed from stainless steel, which is a recyclable material. 
Because they are designed to have a long life they can be used for multiple different purposes. 
Also, the main alloying elements of stainless steel are chromium, nickel and molybdenum. These 
three elements are valuable and can be easily separated from stainless steel. Stainless steel itself is 
typically made from recycled material; 25% end of life products, 35% scrap returned from 
production, 40% raw materials that are just being added (Salman, 2015). 
Societal Influence 
 
 The targeted patient age for our device is between 60-90 years old. Many of these patients 
are not as healthy as they were in the earlier stages of life. Because of this, the current treatment 
of mitral regurgitation is a very invasive surgery for patients of their age. They have to undergo 
open heart surgery with a long recovery time. Patients should wait up to six weeks after surgery 
before driving a car and up to 12 weeks before returning to work. Also immediately after surgery 
there are several symptoms that a patient will experience. For example, loss of appetite, difficulty 
sleeping at night, mood swings and feeling depressed, and experience muscle pain or tightness 
(Murkin, 1999). 
Our device will inserted through port insertion surgery. This is a much less invasive 
procedure than open heart surgery for a full mitral valve leaflet replacement. The recovery time is 
less as well. For 24 hours, the patient cannot drive a car, drink alcohol, or make important personal 
decisions. After a week the patient should be able to resume their usual activities (UW Medicine, 
2015). Allowing the patient to return to their life as fast as possible and not feel as if they have 
missed months of what was happening in the world.  
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 Current mechanical heart valves will put a patient on anticoagulants for the remainder of 
their life. Our device will only need a one-time insertion into the heart by port insertion with no 
need of post medications.  
Political Ramifications  
 
The surgical procedure for correcting mitral regurgitation after myocardial infarction is a 
world-wide procedure typically corrected with the use of a mechanical or biological heart valve. 
Our papillary muscle repositioning device has the potential to advance the cardiovascular field. It 
is an affordable alternative that can be brought into markets around the world. By tackling the 
problem at the papillary muscle, our device avoids the possibility of ripping the leaflets and causing 
additional problems to the mitral annulus.  
However, because our device will be inserted through the heart wall it is classified as a 
class 3 device by the FDA. This means that there is the highest amount of risk with these devices 
and are subject to the highest level of regulatory control. They also must be approved by the FDA 
before being marketed. A current class 3 device on the market are replacement heart valves 
(Whitmore, 2013)  
 Our device falls under the medical device tax which will impose a 2.3 percent sales tax on 
the medical device supplies.  
Ethical Concern 
 
 When designing and biomedical device, an engineer must consider the biomedical ethics 
established by the Belmont report in 1979. The Belmont report considers the three basic principles 
of ethics to consider when a device or research pertains to human subjects: beneficence, respect 
for autonomy, and justice. Our original client statement included the use of fibrin microthreads 
that we were going to seed stem cells onto to help with the regeneration of the papillary muscles. 
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Stem cells have been causing large debates on the ethics of utilizing them. The controversy began 
when scientists discovered they could remove stem cells from human embryos. However, the 
general public did not believe in destroying human embryos (Learn.Genetics, 2016). Through 
research and speaking with our advisors, we realized that stem cells were not needed for the 
completion of our project, so that eliminated the ethical concern of using stem cells. 
We would be using nitinol to reposition the papillary muscle in the hopes to improve the 
lives of patients and eliminating the possibility of mitral regurgitation. Making this correction will 
extend the lifespan of the patient and allow them to continue to live a normal and healthy lifestyle. 
We do consider and respect the patient's decision to not want the device implanted into their body 
or the possibility of the patent not wanting to undergo the port access procedure. 
 An ethical concern that has been raised in previous biomedical implants is the issue of 
human identity and dignity. The question of whether an individual can still be considered human 
once they incorporate an artificial structure and system into their body has been debated for years. 
This controversial topic is one we have considered and will live up to the opinion of the intended 
user.  
Health and Safety Issue  
 
 Nitinol is a biocompatible material, however, there is the potential for hazardous 
contamination. Although nitinol has an oxide layer that prevents corrosion and removes toxic Ni 
atoms from the surface of the material, there is still the potential for these particles to degrade into 
the body causing damage, and in some cases death. There is also the possibility of people being 
allergic to nickel which makes nitinol potentially problematic if exposed to an immune system that 
can not tolerate the material; especially if one were unaware of this allergy. 
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 Another safety issue is that our device will be inserted through port access surgery. 
Although this procedure is less invasive than open heart surgery it still has risks associated with it. 
Port access surgery involves the medical professional inserted tubes into the blood vessels of the 
thigh and neck and threading those tubes through the vessels until the heart is reached. These tubes 
are delivering drugs that stop the heart in order to protect the patient while going through the 
surgery. They are connected to a heart-lung machine which circulates blood through the body 
although the heart is stopped. Then the surgeon makes two small incisions between the ribs, these 
are the “ports”. The surgeon will insert the nitinol papillary muscle repositioning device using one 
of the holes while a miniature camera is inserted in the other (Mohr, 1998). 
Manufacturability  
 
 All materials chosen for our device are easy to manufacture. They are accessible and 
inexpensive products that may be purchased within the United States. Nitinol has begun to increase 
in the industrial and commercial markets. The manufacturing process of nitinol configures and 
programs the shape memory alloy to a specific shape through thermal manipulation between the 
martensitic and austenitic phases based on the intended final use and environment of the nitinol. 
Manufacturing begins with melting and is followed by shaping of material which is typically 
performed by laser machining, wire EDM, swiss machining, and milling. The chemistry behind 
melting nitinol must be performed carefully and precisely. The transformation temperatures are 
very fragile and may cause a imbalance concentration between Ni and Ti. “For alloys having 
greater than 55.0 weight percent Ni, a one weight percent deviation in Ni (or Ti) 2 concentration 
will result in approximately a 100°C shift in transformation temperatures (Wu, 2002).” When 
incorporated in medical devices, nitinol must be electropolished to remove dross, machining 
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artifacts, and heat affected zones resulting from thermo-cutting processes in order to eliminate 
crevices between grains, as well as improve lifespan and performance. 
Silicone Rubber 
 Through the processes of manufacturing the silicone rubber portion of the device, the 
method of choice would be liquid injection modeling. This is a cost effective option that makes it 
easier to make more complicated objects. Since the base has the double circle design with the 
cutouts, it would be easier to use the liquid injection molding. Using liquid injection modeling 
allows for our device to be produced on a large scale due to the simplicity of this method (Dow 
Corning, 2015).  
Stainless Steel 
 The process to manufacture the stainless steel components would be based on the normal 
stainless steel manufacturing process. This is done by using normal alloying methods. Stainless 
steel would be melted and put into the casting of the mold of interest. This would then follow into 
the forming and heat treatment phases that determine the proper mechanical properties. Once the 
shape is made, different quality assurance positions would be tested to ensure that the stainless 
steel would be able to be placed in the heart (Turing, 2015). 
Sustainability  
 
 The materials used to assemble our device are easily accessible as well as readily available. 
The amount of each material for our final product is relatively small and will not cause a major 
consumption of these resources during manufacturing.  
VIII. Conclusion and Recommendations 
 
Through our Major Qualifying Project the engineering design process was heavily 
implemented to create a cost-effective product that meets the client’s needs. We began with 
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understanding that although a client may have an implied solution associated with the initial client 
statement, that does not mean it is the only solution to the problem. The client wanted to address 
the need to treat mitral regurgitation after myocardial infarction with the use of fibrin microthreads. 
However, after conducting research on fibrin microthreads and the causes of mitral regurgitation, 
we discovered a better approach. What the client truly needed was for the mitral valve leaflets to 
return to a location that would allow for proper closure. We did not need to regenerate the papillary 
muscles, we needed to reposition them to create that proper closure of the leaflets. Current devices 
that solved this problem were either very invasive or not a permanent solution. Our device was 
designed to improve upon that by making it minimally invasive through port access surgery as 
well as having it be a one-time surgery for the patient.  
The final device developed was a cantilever papillary muscle repositioning device. The device 
would be inserted into the papillary muscle through the outside of the heart wall allowing to 
reposition the papillary muscle to a position that would allow for proper closure of the mitral valve 
leaflets. The typical displacement seen after myocardial infarction is 2.5-5mm, and the amount of 
displacement per patient would be determine via CT scans. The length of our device determines 
how much displacement will be seen in the movement of the papillary muscle. The range of length 
is 14-15.5mm giving a displacement of 2.7-4.9mm. This was calculated through the use of 
SolidWorks Nitinol Simulations. Determining this range in lengths allows our device to be 
customizable per patient depending on the severity of their papillary muscle displacement.  
There were a few limitations associated with our project however. The biggest limitation that 
occurred from this project was the time constraint. We did not have enough time or resources to 
perform an extensive Finite Element Analysis that would work as our proof of concept of our 
device.  
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 During our experiment, we experienced limitations with the morphology of the hearts. The 
porcine hearts obtained came from a local butcher. When received, many of the hearts had cuts 
that went through the ventricle and in some cases had the papillary muscle cut out or dislocated 
the chordae tendinea. With the internal destruction of important components, it was not possible 
to do accurate dissection.  
Many of the initial specimens developed a moment when compressed against the heart wall 
and resulted in a failed experiment. In order to fix this problem was, nitinol was shortened in length 
to decrease that moment that caused bending, allowing nitinol to enter more efficiently. This 
allowed for accurate results of data.  
Our proof of concept was backed up by the SolidWorks Material Simulation. This is a 
reliable stimulation for our device because it is based on the characteristics of the shape memory 
alloy (SMA) of NiTi. Using an FEA model would have been the best and most ideal method, 
however the CT scans we obtained were not able to be created into a finite element model of the 
left ventricle alone. 
Our project was designed to be a proof of concept, so further testing and research need to be 
conducted. In vitro experiments with the use of porcine hearts were conducted throughout our 
project, however in vivo testing with the use of animal models will be the next step in the 
development of our device. If these tests supported our findings from the year, the device would 
then be moved to clinical trials. This device would also be considered a class 3 device through the 
FDA, making it more difficult to gain approval. And finally further research would have to be 
conducted on the cost of our device and if insurance would be able to cover the expenses, so that 
our device could be available for a large population.  
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